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Abstract:  
Cryptic genetic variation can facilitate adaptation in evolving populations. To elucidate the 
underlying genetic mechanisms, we used directed evolution in E. coli to accumulate variation in 
populations of yellow fluorescent proteins, and then evolved these proteins towards the 
phenotype of green fluorescence. Populations with cryptic variation evolved adaptive genotypes 5 
with greater diversity and higher fitness than populations without cryptic variation, which 
converge on similar genotypes. Populations with cryptic variation accumulated neutral or 
deleterious mutations that break the constraints on the order in which adaptive mutations arise. In 
doing so, cryptic variation opens paths to adaptive genotypes, creates historical contingency, and 
reduces the predictability of evolution by allowing different replicate populations to climb 10 
different adaptive peaks and explore otherwise inaccessible regions of an adaptive landscape.  
One Sentence Summary: Cryptic genetic variation opens paths to selectively inaccessible 
regions of protein sequence space. 
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Main Text:  
Cryptic genetic variation is standing genetic variation that does not normally contribute to 
heritable phenotypic variation in a population, but that can bring forth phenotypic variation after 
environmental change or genetic perturbation (1, 2). Cryptic variation exists because phenotypes 
are to some extent robust to genetic change (3–6). Because of its potential role in adaptive 5 
evolution, cryptic variation has attracted widespread interest (7–17), but supporting experimental 
evidence is limited (1, 17–19). One distinguishing feature of cryptic variation is that the 
conditions inducing its phenotypic effects are rare or absent in a population’s history. In 
consequence, it can be protected from selection until a new environment arises in which cryptic 
variation may give rise to new and potentially beneficial phenotypes (1, 2). The molecular 10 
mechanisms of adaptation under cryptic variation are difficult to study for complex phenotypes 
of whole organisms, because their genetic basis often remains elusive (17, 20). Such mechanisms 
are better studied with simple and tractable systems such as evolving proteins. Many mutations 
in proteins interact epistatically (i.e., non-additively), which can render adaptive landscapes 
rugged and multi-peaked (21–26). An evolving population’s location on a rugged adaptive 15 
landscape influences which of these peaks are accessible (26–28). These observations hint that 
cryptic variation may help populations of evolving proteins enter regions of an adaptive 
landscape that would otherwise remain inaccessible. 
Results 
To create cryptic genetic variation, we subjected each of four replicate populations of yellow 20 
fluorescent protein (YFP; populations VC, ‘C’ for cryptic) to four rounds (‘generations’) of 
directed evolution subject to stringent stabilizing selection to maintain yellow fluorescence 
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(phase I; Figs. 1, S1). Specifically, we evolved a population of ~5×106 YFP variants in each 
generation and in each replicate population, which we subjected to PCR mutagenesis (0.84 
amino-acid changing mutations per YFP molecule per generation, Tables S1, S2). In every 
generation of phase I, we allowed only those 20% of cells of evolving populations to survive 
whose yellow fluorescence intensity lay in a narrow interval around the median of ancestral YFP 5 
(Fig. 1, (29)). Such stringent stabilizing selection allows the accumulation of cryptic variation, 
because only the mutations (or their combinations) that have little effect on yellow fluorescence 
can persist. We then initiated phase II, in which we subjected the same populations to four 
generations of stringent directed evolution towards green fluorescence (Fig. 1). As controls, we 
also subjected four populations (called V0, for zero initial cryptic variation) that started from 10 
identical ancestral YFP molecules to four generations of evolution towards green fluorescence. 
We then compared the change in green fluorescence intensity during phase II in populations VC 
with that of the control populations V0. Populations VC reached significantly higher green 
fluorescence during three out of the four generations of evolution in phase II (Fig. 2A), and they 
adapted approximately three times faster during the first generation of phase II (Fig. S2A). In 15 
addition, populations VC more rapidly evolved a green (512nm) emission peak than populations 
V0 (Fig. 2B). At the evolutionary endpoint, three of four VC populations showed significantly 
greater green fluorescence than the four V0 populations (Two-way ANOVA: F7,16=46.5, 
P=1.99×10-9; post hoc Tukey’s test, P<0.05 for VC replicate 1, 2 and 4 relative to the four V0 
populations; Fig. 2C and Table S3). In sum, the genetic variation accumulated in phase I 20 
facilitated the evolution of green fluorescence during phase II. 
To study why this genetic variation facilitated adaptive evolution, we used single molecule real 
time sequencing (SMRT) to genotype ~500-1000 evolved variants for each replicate population 
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and for each generation (Table S4). We first noticed that VC populations were more diverse than 
V0 populations throughout phase II. Specifically, they harbored on average more mutations per 
individual molecule (Fig. 3A). They also showed a broader distribution of mutations per 
individual molecule (Fig. S2B), as well as greater overall genetic diversity (Fig. S2C, (29)). 
Additionally, the four VC populations diverged to a much greater extent from each other (Figs. 5 
3B, S2D).  
We then studied the dynamics of polymorphisms in each replicate population during phase II 
(Fig. S3A, (29)) and observed that two mutations (G66S and Y204C) swept through all replicate 
V0 and VC populations, with two other mutations (F65L or F47L) achieving high or medium 
frequency (>10%) in two or more V0 populations, and in one or two VC populations. Because of 10 
their ubiquity, we refer to these four mutations as typical mutations (Fig. S3B). At the 
evolutionary endpoint, most of these mutations co-occurred in three similar and high frequency 
genotypes that share the two mutations G66S and Y204C, and that harbor one additional 
mutation each, i.e., F65L, F47L, and L43M. We refer to these genotypes as T1, T2, and T3 or 
typical genotypes (Fig. 3C, D), and to the combination of G66S and Y204C mutation as 15 
genotype T.  
Populations VC evolved differently from populations V0. First, seventeen alternative mutations 
attained a frequency of more than 10% in VC populations but in none of the V0 populations 
(except the mutation V164A which reached a frequency of 10.9% in 04V ; Fig. S3A). Also, typical 
genotypes dominated only one replicate VC population (number 2), in contrast to their 20 
importance in V0 populations. The remaining populations were dominated by one or two of four 
other, alternative genotypes (A1-A4), which contain some combination of eleven alternative 
Submitted Manuscript: Confidential 
6 
 
mutations in the genetic background T (Fig. 3C, D). We measured the green fluorescence 
intensity of the three typical genotypes as well as of the four alternative genotypes (29). Three of 
the alternative genotypes exhibited greater green fluorescence than all typical genotypes (Fig. 
3E).  
In sum, during directional selection for green fluorescence (i) more diverse genotypes attain high 5 
frequency in populations VC than in populations V0; (ii) different alternative genotypes dominate 
each of three replicate populations VC, and (iii) three of the four alternative genotypes had 
significantly higher green fluorescence than all three typical genotypes.  
Because VC populations evolved faster in phase II than V0 populations (Fig. 2A), we suspected 
that some of their adaptive mutations or genotypes accumulated in phase I. We thus studied the 10 
phase I evolutionary dynamics of the four typical mutations and eleven alternative mutations 
(Fig. S4A). All fifteen mutations were already present above our phase I detection limit of 0.064-
0.16 percent(29), and eleven of the fifteen mutations reached frequencies between 0.5% and 
2.5% in at least one of the VC populations. This demonstrates that the variants accumulated in 
phase I are relevant to the exploration of different high-fitness genotypes in phase II. We 15 
performed additional directed evolution experiments starting from the YFP ancestor, but in the 
complete absence of selection, which allowed us to determine how fast individual variants would 
increase in frequency through mutation alone. High throughput sequencing showed that the 
frequency of all but one (F47L) of the mutations had not increased significantly more than 
expected by mutation pressure alone during phase I (Two-way Ancova with Holm adjustment, 20 
P=9.11×10-5; Fig. S4B). Specifically, 93.3 percent (14 of 15) of the genetic variants that were 
involved in adaptive evolution during phase II were not subject to positive selection in phase I. 
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These observations demonstrated that most genetic variation that was adaptive in phase II 
accumulated cryptically during phase I.  
Because the typical and alternative genotypes were also the genotypes with the highest green 
fluorescence in each replicate population at the evolutionary endpoint (Figs. 3E, S5, S6; Table 
S5), we wanted to identify the accessible evolutionary paths to these genotypes (Fig. S5, (29)). 5 
Each step on such a path involves a single point mutation, and we distinguish two kinds of steps, 
an accessible mutational step that increases green fluorescence significantly, and an inaccessible 
step that does not. We call a path inaccessible if it contains at least one inaccessible step. We first 
engineered all mutations leading to each of the typical genotypes (T1-T3) into the ancestor, and 
measured their green fluorescence to determine path accessibility. No less than one third of paths 10 
to the typical genotypes are accessible (Fig. 4A, B).  
We then engineered and analyzed the mutations leading to the alternative genotypes A1-A4, and 
found that these genotypes are much less accessible (Figs. 4A, B, S5, S6; (29)). For example, 
genotype A2, which had the highest green fluorescence among all typical and alternative 
genotypes, can be accessed by only 3.3% of all mutational paths (Figs. 4B, S6; (29)). The reason 15 
is that two mutations in this genotype (F72I and I172V) enhance green fluorescence only after 
the arrival of two other mutations (G66S and Y204C), and the remaining constituent mutation 
(K167E) only becomes beneficial once the four other mutations have arrived. An even more 
extreme example is the alternative genotype A1, because no path to it is accessible. Four of its 
six constituent mutations decrease green fluorescence both in the wildtype background, and also 20 
in the presence of the remaining two mutations, which suffices to block each path (Figs. 4A, S5; 
(29)).  
Submitted Manuscript: Confidential 
8 
 
We next examined our sequence data to study the order of mutations by which evolving 
populations approached those high fitness genotypes that have the highest frequency in any one 
generation and population (Fig. 4C). All four V0 populations followed similar mutational paths to 
each of the three typical genotypes T1-T3 (Fig. 4C). They first acquired either mutation G66S or 
Y204C, which arose to an average frequency of 20.1 % after the first generation of phase II (II-5 
1). Next evolved the genotype T (G66S+Y204C), which reached a frequency of 9.2% one 
generation later. After that arose genotypes T1, T2 and T3, which incorporate the additional 
mutations F65L, F47L and L43M, respectively. They show even higher green fluorescence (Fig. 
S5), and reached a frequency of 18.2% in generation three (Fig. 4C). Inaccessible genotypes play 
no major role in these evolutionary dynamics, because their frequency remains low in 10 
populations V0 (Fig. 4C).  
These evolutionary dynamics differ from those observed in populations VC with cryptic 
variation. Here, intermediate genotypes that would be inaccessible during selection for green 
fluorescence steadily increased in frequency already before such selection started. At the end of 
phase I, the collection of all such genotypes had already reached a frequency of 16.9% in Vc 15 
populations (Fig. 4C). These otherwise inaccessible intermediate genotypes served as stepping 
stones towards high green fluorescence in phase II, as shown by a transition from inaccessible 
intermediate genotypes to high-fitness genotypes early in phase II (Fig. 4C). Specifically, 
inaccessible intermediate genotypes reached a frequency of 26.5% in VC populations in the first 
generation of phase II, which enabled a rapid increase in the frequency of high-fitness genotypes 20 
to 28.7% only one generation later.  
We then studied the evolutionary dynamics leading to specific typical and alternative genotypes, 
which provides further support for our hypothesis that cryptic variation can help explore 
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alternative trajectories and peaks (Figs. 4B, S7; (29)). One example involves the evolution of 
alternative genotype A4 in population 4
CV , where the occurrence of a crucial intermediate 
genotype (Y204C+F72C+I168V) that was inaccessible under selection for green fluorescence 
had been facilitated by phase I. Specifically, we detected all three constituent mutations of this 
intermediate genotype at the end of Phase I (Table S6).  The intermediate genotype itself 5 
appeared in the first generation of phase II, and genotype A4, which harbors one additional 
mutation (G66S), had already attained a frequency of 27.9% one generation later (Fig. S7; (29)).  
Discussion 
Taken together, our observations indicate that cryptic variation helps populations not only 
traverse otherwise inaccessible trajectories to high fitness genotypes, it also helps them access 10 
diverse high fitness genotypes (Fig. 4D). When populations are exposed to stabilizing selection 
while they diverge from an ancestral genotype (Fig. 4D, blue open circle), they may accumulate 
cryptic genetic variation (Fig. 4D, red open circles). An environmental change that alters 
selection pressure can alter the adaptive landscape on which such populations evolve and create 
new fitness peaks (Fig. 4D, upper panel). If a population without variation starts to adapt to a 15 
new environment, it may reach a nearby fitness peak (Fig. 4D, solid blue circles in upper panel), 
but will not climb other, higher peaks if reaching such peaks requires traversing inaccessible low 
fitness genotypes. In contrast, populations with cryptic variation may reach these peaks (Fig. 4D, 
solid red circles in upper panel), if the necessary genetic stepping stones have arisen before the 
environmental change.  20 
Sign epistasis, where a DNA mutation can change the sign of its effect on fitness from beneficial 
to detrimental in the presence of other mutations, is a source of complex, multi-peaked 
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topographies in adaptive landscapes (23, 30, 31). Sign epistasis is widespread in proteins and 
RNA (26, 30, 32–35).  It can create fitness plateaus or valleys, which constrain the order in 
which adaptive mutations occur, and slow down or prevent the ascent of peaks in an adaptive 
landscape (25, 30–32).  How evolving populations can overcome such obstacles is a central 
question in evolutionary biology (1, 36, 37). Computational or phylogenetic studies suggest that 5 
fitness-valley crossing may be a common phenomenon (38, 39). In addition, theory proposes that 
cryptic genetic variation can facilitate fitness-valley crossing (40, 41), but experimental evidence 
is still wanting.  Our experiments demonstrate how cryptic variation can facilitate this process. 
During stabilizing selection on an ancestral phenotype, a population can accumulate not only 
neutral mutations, but also mutations that would be deleterious when selection favors a novel 10 
phenotype. Such mutations can become stepping stones towards the novel phenotype. For 
example, one of our populations with cryptic variation (and none of those without) reached the 
high fluorescence genotype A1 because multiple stepping stone variants had arisen during earlier 
stabilizing selection for yellow fluorescence. Furthermore, because different populations 
stochastically accumulate different cryptic variants, such cryptic variation creates stochasticity 15 
and historical contingency that not only reduces the predictability and reproducibility of 
evolution, but that can also uniquely solve evolution’s problems (Fig. 3C, D).  
Evolving populations of whole organisms with different initial fitness sometimes converge on 
similar fitness (42, 43). The pervasive epistasis between amino acid changing mutations makes 
such convergence less likely for our protein populations, because proteins with different, 20 
epistatically interacting mutations often tend to evolve distinct genotypes and, in consequence, 
achieve quite different fitness (28, 44).  
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When directed evolution relies on large populations sizes (45), it can lead to repeatable 
evolutionary outcomes that cannot be further improved (46, 47). Small populations with strong 
neutral drift can be more effective (48, 49), but small populations will also accumulate limited 
diversity. In contrast, large populations subject to stabilizing selection will not only accumulate 
substantial cryptic variation, but may also uncover different high fitness phenotypes during 5 
subsequent directional selection on a new phenotype. Our observations call for experiments 
where many and large populations are evolved in parallel, first to accumulate cryptic variation 
during stabilizing selection on an existing phenotype, and then to find different novel phenotypes 
during directional selection, such as for a novel biomolecule. This approach may work when 
conventional directed evolution fails.  10 
Directed evolution experiments require high mutation rates in order to observe adaptive 
evolution on laboratory time scales. Such high mutation rates can generate multiple beneficial 
mutations that compete with each other through clonal interference. In consequence only the 
most strongly beneficial mutations may survive, leading to ‘greedy’ adaptation and repeatable 
outcomes (50–52), as in our V0 populations (Fig. 3). In addition, large mutation rates can also 15 
increase the chance that deleterious mutations can hitchhike with beneficial mutations, which can 
facilitate fitness-valley crossing (52). However, we did not observe such valley-crossing in our 
populations V0 (Fig. S7), perhaps because of the stringent selection in our experiment, where 
only 0.01% individuals survived every generation during phase II (Fig. 1). Such selection may 
purge deleterious mutations before compensatory mutations can arise (51). Consistent with this 20 
hypothesis, intermediate inaccessible genotypes stayed at a low frequency in V0 populations, 
whereas they steadily decreased in VC populations during phase II evolution (Fig. 4C).  
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In sum, our results illustrate why cryptic variation cannot only help populations overcome 
obstacles to adaptive evolution, but also find multiple routes around such obstacles. The sign 
epistasis that creates such obstacles is involved in processes as different as the evolution of 
sexual reproduction (53), the divergence and reproductive isolation of species (54) and the 
development of human diseases (55). By breaking its constraints, cryptic variation may thus have 5 
far-reaching effects on many biological processes. 
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Legends 
Fig. 1. Experimental evolution of yellow fluorescent protein. In phase I, we subjected four 
replicate populations of yellow fluorescent protein (YFP) to four generations of directed 
evolution under stabilizing selection for the native yellow fluorescence, allowing only those  
~20% of cells closest to the median (dashed vertical line) of ancestral yellow fluorescence (VC, 5 
λex=488nm and λem=530±15nm, (29)). In phase II, we subjected these populations to four 
further generations of strong directional selection for green fluorescence, allowing only 0.01% of 
cells to survive (λex=405nm and λem=525±25nm, (29)). As controls, we subjected four 
populations (V0) consisting of initially identical YFP molecules to the same stringent directed 
evolution for green fluorescence (29).  10 
Fig. 2. Cryptic variation leads to faster color change and higher fluorescence. (A) Fold-
change of yellow and green fluorescence intensity relative to the ancestral YFP during phase II 
evolution (29). Error bars represent one SEM, from four replicate populations (thin lines). Note 
the logarithmic vertical scale.* P<0.05, ** P<0.01 (One-sided t-tests with Holm adjustments). 
(B) Emission spectra (shown as mean values of four replicate populations) of evolving 15 
populations V0 and VC at the new excitation wavelength (405nm) in phase II (29). The vertical 
axes indicate the relative fluorescence intensity at a given emission wavelength (horizontal axis) 
relative to the maximal fluorescence intensity at the emission peak 512nm (green vertical dashed 
line). (C) Fold-change of green fluorescence intensity relative to the ancestral YFP for each 
replicate population at the evolutionary endpoint. Error bars denote SD (n=3, (29)).   20 
Fig. 3. Cryptic variation helps explore diverse high fluorescence genotypes. (A) Number of 
amino acid changes per protein sequence based on genotyping hundreds of evolved variants in 
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each population using SMRT sequencing. * P<0.05, ** P<0.01, **** P<0.0001 (One-sided t-
tests). Thick lines indicate means for populations V0 or VC over four replicate populations (thin 
line), and error bars denote SEM. (B) Average number of amino-acid differences (at the 
evolutionary endpoint) between all protein sequences in the labeled populations (29). (C) Cryptic 
variation helps explore diverse genotypes. Each circle (node) represents a genotype that has been 5 
observed during evolution. An edge connects two genotypes if they differ in a single amino-acid. 
Colored circles represent genotypes that exclusively occur in a single replicate population, where 
circle area (logarithmic scale) corresponds to genotype frequency. White and grey circles 
indicate genotypes that were not observed in populations, or that were observed in at least two 
replicate populations at the endpoint, respectively. Sizes of grey circles correspond to the highest 10 
frequencies of the corresponding genotypes in those replicate populations. Dashed ovals 
circumscribe each labeled high fluorescence genotype, together with the genotypes composed of 
subsets of its constituent mutations. (D) The frequency of constituent mutations of typical and 
alternative genotypes in each replicate population at the evolutionary endpoint. The alternative 
genotypes A1, A2, A3 and A4 comprise the unique mutation combinations 15 
F65S/K102R/N145S/V164A, F72I/K167E/I172V, I129T/K141R and F72C/I168V, respectively. 
In addition, each of these genotypes also harbors the mutations T (G66S+Y204C), and genotype 
A1 also harbors the mutation F47L. (E) Fold-change in green fluorescence intensity of each 
typical (blue) or alternative (red) genotype relative to the ancestral YFP (Note that here A1 does 
not contain the mutation K102R because K102R does not significantly improve green 20 
fluorescence; Table S5). Error bars denote SD (n=3 or 6). * P<0.05, ** P<0.01, *** P<0.001 and 
**** P<0.0001 (One-sided t-tests with Holm adjustments).  
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Fig. 4. Cryptic variation enables the exploration of alternative high fluorescence genotypes. 
(A) Accessibility of mutational paths to two representative genotypes, the typical genotype T1 
and the alternative genotype A1 (Note that the mutation K102R is not shown because it does not 
significantly improve A1’s green fluorescence; Table S5). Blue solid lines indicate an accessible 
mutational step, which increases green fluorescence significantly, and dashed lines indicate an 5 
inaccessible step, which does not increase green fluorescence significantly. Solid red lines 
indicate a conditionally accessible step that significantly increases green fluorescence in the 
genetic background where it occurs, but where the ancestral YFP must first experience one or 
more inaccessible steps to create this kind of genetic background. We call a path inaccessible if it 
contains at least one inaccessible step, and consider a difference in green fluorescence between 10 
genotypes as significant if P<0.05 (Two-sided t-test with Holm adjustment). (B) Percentage of 
accessible mutational paths to typical genotypes and to alternative genotypes, as well as 
accessibility inferred from mutation rates and genotype frequencies (29).The right-most entry 
indicates which populations harbored the genotype.  (C) Evolutionary trajectories as indicated by 
frequency changes  of mutants G66S and Y204C, of genotype T (G66S+Y204C), of all high-15 
fitness genotypes that had significantly higher green fluorescence than genotype T (Figs. 3E, S5), 
as well as of all intermediate genotypes (averaged) leading to these high fitness genotypes that 
are inaccessible through selection for green fluorescence alone. Error bars denote SEM (n=4). 
Each circle indicates data from one replicate population. (D) A schematic illustration of how 
cryptic genetic variation can accelerate adaptation and provide access to diverse adaptive peaks 20 
(see text for details).  
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Materials and Methods 
Strains and Plasmids 
We used E. coli strain BW27783 (CGSC 12119) for preparing YFP mutant libraries, which 
enables the homogeneous expression of the arabinose-inducible araBAD promoter in E. coli 
(56). We used the plasmid pBAD202/D-TOPO® (K4202-01, Invitrogen) as the vector for YFP 
evolution. It carries an arabinose-inducible araBAD promoter and a Kanamycin resistance 
marker.  
Preparation of electro-competent cells 
We prepared electro-competent cells using glycerol/mannitol step centrifugation (57). 
Briefly, we grew E. coli strain BW27783 in 5 mL SOB medium at 37°C and 250 rpm overnight. 
We transferred 3 mL culture into 300 mL SOB medium the next morning and continued to 
incubate the transferred culture at 37°C and 250 rpm until its OD600 had reached a value between 
0.4 and 0.6 (optical path length: 1 cm, 2-4 hours). We cooled the culture on ice for 15 min and 
collected cells at 4°C by centrifuging at 1,500 g for 15 min. We used 60 mL ice-cold ddH2O to 
suspend the cells and distributed them into three 50 mL tubes. Then we slowly added 10 mL ice-
cold glycerol/mannitol solution (20% glycerol (w/v) and 1.5% mannitol (w/v)) to the bottom of 
each tube by using a 10 mL pipette. We centrifuged the tubes at 1,500 g and 4°C for 15 min in a 
centrifuge (Eppendorf 5810/5810 R) by setting acceleration/deceleration to zero. We removed 
the supernatant and suspended the cells in 3.0 mL ice-cold glycerol/mannitol solution. We 
transferred 100 µL of the resulting suspensions into pre-cooled 1.5 mL tubes and incubated them 
in a dry ice-ethanol bath for ~1 min. Then we stored the suspensions at -80°C for transformation 
experiments. 
Electro-transformation 
We mixed 4 µL of ligation product with 100 µL of electro-competent BW27783 cells. We 
transferred the mixture into a 0.2 cm cuvette (EP202, Cell Projects, UK), and then used a 
Micropulser electroporator (Bio-Rad) set at EC3 (15k V/cm) for transformation. We immediately 
added 1 mL of pre-warmed SOC medium after electroporation and transferred the culture into a 
10 mL tube. We incubated the culture for 1.5 h at 37°C with shaking at 220 rpm in a shaking 
incubator (INFORS HT, Switzerland), and used the recovered transformants for further 
experiments. 
Construction of the expression plasmid 
We designed the primers Fbad/Rbad (Table S8), which contain XhoI and HindIII restriction 
sites, to amplify the vector backbone of pBAD202/D-TOPO® by PCR. The resulting 
amplification product contained novel XhoI and HindIII restriction sites upstream of the original 
restriction sites NcoI and PmeI, and harbored a deletion of the DNA fragment between the latter 
two restriction sites (including the NcoI site). In addition, we designed the primers F203/R203 
(Table S8) to amplify the coding region of YFP from the plasmid pAND (58) and to introduce 
XhoI and HindIII restriction sites upstream of its  ATG start codon and downstream of its TGA 
stop codon, respectively.  
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To amplify both DNA molecules, we performed a 50 µL PCR reaction, consisting of 10 ng 
template plasmid, 400 µM dNTPs, 5.0 U Phusion Hot Start II High-Fidelity DNA Polymerase, 
10 µL 5× Phusion HF Buffer and 400 nM each primer. We performed the PCR reaction for 
amplifying the vector backbone of pBAD202/D-TOPO® with the following program: 98°C/30 s; 
10 cycles of 98°C/10 s, 54°C/15 s and 72°C/80 s; 15 cycles of 98°C/10 s, 68°C/15 s and 72°C/80 
s; 72°C/5 min. And we used the following the program to amplify the coding region of YFP: 
98°C/30 s; 10 cycles of 98°C/10 s, 66°C/15s and 72°C/30s; 15 cycles of 98°C/10 s and 72°C/30 
s; 72°C/5 min.  
To remove the template plasmid from the PCR product, we incubated the product with 10 U 
of DpnI (R0176S, NEB) at 37°C for 2 h. To inactivate DNA polymerase, we added 0.6 U of 
proteinase K (EO0491, Thermo Scientiﬁc), followed by incubation at 50°C for 1h, and by 15 
min of inactivation at 80°C. We then added 20 U XhoI/HindIII-HF (R0146L/R3104S, NEB), 
incubated at 37°C overnight, and inactivated the restriction enzymes at 80°C for 20 min. We 
used the QIAquick Gel Extraction Kit (Qiagen, Germany) to purify the digested vector 
backbones, and used the QIAquick PCR puriﬁcation kit (Qiagen, Germany) to purify the 
digested YFP products. 
We mixed 60 ng of purified YFP fragment, 100 ng of purified vector backbone, 10 U of T4 
DNA ligase, and 2 µL of 10×Ligation buffer (M0202L, NEB) in a 20 µL of ligation reaction. We 
incubated the mixture at 20-22°C for ~16 h, followed by 10 min of inactivation at 65°C. To 
purify the ligation product, we first precipitated it by adding 1 µL of glycogen (R0551, Thermo 
Scientiﬁc), 50 µL of 7.5 M ammonium acetate (A2706-100ML, Sigma), 375 µL of ice-cold 
absolute ethanol, and 80 µL of ddH2O. After incubation at -20°C for 20 min, we centrifuged the 
mixture at 18,000 g for 20 min. We washed the precipitate twice using 800 µL of cold ethanol 
(70%). After drying the precipitate using an Eppendorf concentrator 5301, we dissolved it in 10 
µL of ddH2O.  
We used 4 µL of purified ligation product for transformation according to the protocol 
described above. Then we diluted 10 µL of an aliquot of transformed cells using saline, and 
plated the serially diluted aliquot on LB agar containing 25 μg/mL of kanamycin. After 
incubation at 37°C overnight, we choose three colonies for colony PCR to identify transformants 
harboring the appropriate vector construct. We extracted the plasmids of these colonies and 
subjected them to double restriction-enzyme digestion and Sanger sequencing. Finally, we chose 
one correctly constructed plasmid (named pBAD-EY) with YFP inserted for the following 
experiments. 
Mutagenic PCR 
For the evolution of YFP populations, we introduced mutations into the coding region of 
YFP using mutagenic PCR. In brief, we performed mutagenic PCR in a 100 µL volume with 10 
ng of template plasmid, 400 µM of dNTPs (R0192, Thermo Scientiﬁc), 3 µM of 8-oxo-
GTP/dPTP (Trilink Biotechnologies), 2.5 U of Taq DNA polymerase (M0267L, NEB), 10 µL of 
10×ThermoPol buffer (M0267L, NEB), and 400 nM of each primer (MutafpF/MutafpR, Table 
S8). We performed 25 cycles of PCR, as follows: 95°C/30 s; 25 cycles of 94°C/20 s, 46°C/30 s 
and 68°C/50 s; 68°C/5 min. We treated PCR products by following the procedure described in 
Construction of the expression plasmid to obtain linearized inserts (mutated YFP pools). We also 
 
 
4 
 
digested and purified the plasmid pBAD-EY following the procedure described in Construction 
of the expression plasmid. We then used 5 U of Antarctic Phosphatase (M0289S, NEB) to 
dephosphorylate the puriﬁed vector backbone and purified the dephosphorylated vector 
backbone using the QIAquick PCR puriﬁcation kit. We followed the procedure described in 
Construction of the expression plasmid to perform the ligation reaction and purify the ligation 
products. The ligation products served as substrates for the E.coli transformation described 
above. SMRT sequencing indicated a mutation rate of 1.04 nucleotide changes per YFP 
molecule and generation of mutagenesis (Table S 1), and allowed us to estimate the extent of the 
A→G and T→C mutation bias (Table S9) that PCR mutagenesis is well-known to cause (59). 
Evolution of YFP under selection for yellow fluorescence 
We performed electro-transformation as described above, using 4 μL of the mutagenized 
YFP library ligated to the vector backbone. Then we added 10 mL of LB medium supplemented 
with 30 μg/mL of kanamycin to the recovered culture in a 50 mL tube, and incubated the culture 
at 37°C overnight, with shaking at 220 rpm. To estimate library size during every generation of 
directed evolution, we also sampled 100 μL of the recovered culture and plated the serially 
diluted aliquot (in saline) on LB agar with 25 μg/mL of kanamycin. This procedure yielded a 
library size of ~106 colonies. Subsequently, we transferred 1 mL of the overnight culture into 10 
mL LB medium with 55 μg/mL of kanamycin, and incubated the cell culture at 37°C with 
shaking at 220 rpm until it had reached an OD600 of 1.0~1.5 (optical path length: 1 cm). Then we 
transferred 200 μL of culture to a 10 mL tube containing 2 mL LB medium (supplemented with 
55μg/mL of kanamycin), and incubated further until the culture had reached an OD600 of ~0.6. 
We added 22 μL of 20% arabinose and incubated the culture at 37°C with shaking at 220 rpm to 
induce expression of YFP. After 12 h of incubation, we sampled 400 μL of the culture and 
centrifuged it at 8000 g and 4°C for 3 min. We washed cells once using 1 mL of cold PBS buffer 
and suspended them in 1 mL of cold PBS buffer for fluorescence-activated cell sorting (FACS).  
We sorted cells at 4°C with an Aria III cell sorter (BD Biosciences), using the FITC channel 
(λex=488nm, λem=530±15nm) and a sorting speed of ~4×104 events/s. We used the sort precision 
of 4-Way Purity to make sure that only droplets free of contaminating particles would be sorted. 
We selected cells according to the selection criteria described in Fig. 1. We note that the ability 
to select cells within a narrow phenotypic bandwidth (Fig.1) is a great advantage of fluorescent 
proteins for directed evolution. It comes from the ability to measure fluorescence in individual 
cells and would be difficult to match with other proteins, such as antibiotic resistance proteins. 
For each replicate population, we collected 106 selected cells in ~1 mL of cold PBS buffer 
(4°C). We placed selected cells on ice to prevent cell proliferation or death before the subsequent 
steps. As the first of these steps, we transferred the selected cells into 1 mL of LB medium in a 
10 mL tube, and incubated them at 37°C for 30 min without shaking. We sampled 5 μL of this 
culture and diluted it 200-fold in saline. We plated this diluted cell aliquot on LB agar (25μg/mL 
of kanamycin) to estimate the post-selection library size, which we did for every generation of 
directed evolution. We incubated the remainder of the culture at 37°C and 220 rpm for 2 h, and 
added 3 mL LB medium (supplemented with 50μg/mL of kanamycin) to each tube for further 
incubation overnight. We added 400 μL of 50% glycerol to 600 μL of overnight culture, and 
stored the mixture at -80°C for the fluorescence assays described further below. In addition, we 
sampled 2 mL of overnight culture and extracted the plasmids using the QIAprep spin miniprep 
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kit (Qiagen, Germany). We used the isolated plasmids as templates for the next mutation-
selection cycle. After four mutation-selection cycles, we used the isolated plasmids as starting 
templates for evolution under selection for green fluorescence, and also for SMRT sequencing. 
In addition to these experiments, we also evolved four replicate populations (dubbed Nsel1-
4), following the same procedure as for populations VC except for collecting all generated 
variants in each replicate population and in each generation, regardless of their fluorescence. In 
comparison to populations VC, populations Nsel1-4 thus did not experience selection on yellow 
fluorescence. They served as controls to determine changes in mutant frequencies that occurred 
in the absence of selection. 
Evolution of YFP under selection for green fluorescence 
We performed electro-transformation as described above, using 4 μL of the ligation product 
between a mutagenized YFP library and the vector backbone. Specifically, we electro-
transformed 4 μL of ligation product into 100 μL of electro-competent BW27783 cells and 
induced YFP expression by arabinose, following the same procedure as described above. We 
sorted fluorescing cells as described above, except that we used the AmCyan channel (λex=405 
nm and λem=525±25 nm) and the criterion for selecting green fluorescing variants depicted in 
Fig.1. We used the sort precision of Single Cell Purity to make sure that only droplets free of 
contaminating particles would be sorted, and that only particles centered within the sorted drop 
would be deflected. During selection for green fluorescence, we selected 5×104 cells in the top 
1% of green fluorescence intensity (measured as AmCyan-H). We re-grew the sorted cells and 
repeated the sorting process by selecting 104 cells in the top 1% of green fluorescence intensity. 
Just as for selection for yellow fluorescence, we used plasmids isolated from sorted cells as 
templates for the next mutation-selection cycle, and stored sorted cells at -80°C in preparation 
for the fluorescence assays described below. We used YFP variants isolated after each generation 
of evolution for SMRT sequencing.  
Engineering YFP variants 
We designed primers (Table S10) that carried the necessary mutations to engineer single 
mutants and some double mutants (F65L+G66S, F65S+G66S, G66S+F72C and G66S+F72I) by 
whole plasmid PCR. To engineer these individual mutations in the genetic background of G66S, 
Y204C, and G66T+Y204C, we performed whole plasmid PCR by using the variants carrying 
G66S, Y204C or G66T+Y204C as templates, employing appropriate primers (Table S10). A 40 
μL PCR reaction consisted of 10 ng template plasmid, 0.8μL 10mM dNTPS, 0.4 μL Phusion Hot 
Start II High-Fidelity DNA Polymerase (F549L, Thermo Scientific), 8 μL Phusion HF buffer, 
1.2 μL DMSO and 0.8 μL 10 μM primers. We performed the PCR reaction with the following 
program: 98°C/1min, 8 cycles of 98°C/20s, 68°C/20s and 72°C/2min, 20 cycles of 98°C/20s and 
72°C/2min, 72°C/5min. We digested the PCR product with DpnI at 37°C for 2 hours to remove 
the template plasmid, followed by incubation at 80°C for 20min to inactivate the enzyme. Then 
we directly used 1 μL of the reaction for electroporation.  
We used the primers G66Sf/Y204Cr and Y204Cr/G66Sf (“f” and “r” indicate the forward 
(f) and reverse (r) primers carrying the corresponding mutation) to amplify the plasmid pBAD-
EY carrying the ancestral YFP, and assembled the resulting two DNA fragments by Gibson 
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PCR, which yielded the double mutant G66T+Y204C. We engineered the rest of the multiple 
mutants by Gibson PCR using the appropriate primers in Table S10. We used the same PCR 
reaction system and program as in whole plasmid PCR, except for the PCR extension time, 
which equaled 30s per 1 kb and varied from 10s to 2min, depending on the length of amplified 
DNA fragments. We digested the PCR product with DpnI at 37°C for 2 hours to remove the 
template plasmid, followed by column purification using the QIAquick PCR purification kit 
(Qiagen, Germany). We added 2 μL mixture of purified DNA fragments with overlapping ends 
to 2 μL 2×Gibson Assembly Master Mix (using the recommended amount of fragments in the 
protocol, E2611S, NEB), and incubated at 50°C for 20 min in a thermocycler. Then we used 1 
μL of the reaction for electro-transformation.  
After electro-transformation, we diluted the recovery culture ten-fold (for cells transformed 
with Gibson PCR product) or 100-fold (for cells transformed with whole plasmid PCR product). 
We plated the resulting dilution on LB agar with 25 μg/mL kanamycin (Sigma 60615), and 
incubated at 37°C overnight. We choose three or six colonies from each transformation to 
validate the construction by colony PCR and Sanger sequencing. We inoculated correctly 
engineered mutants into 2 mL LB with 50 μg/mL of kanamycin, and incubated at 37°C and 220 
rpm overnight. We mixed 900 μL overnight cultures with 600 μL 50% glycerol, and stored the 
glycerol stock at -80°C for the further experiments. 
Inducible expression of evolving populations and engineered variants 
To induce the expression of YFP variants in evolving populations, we allowed the glycerol 
stock of sorted cells from each generation of directed evolution to thaw on ice, and then 
transferred 100 μL of this stock into 2 mL LB medium (supplemented with 33μg/mL of 
kanamycin). We incubated the resulting cell suspension at 37°C with shaking at 220 rpm 
overnight. Then we transferred 200 μL of the resulting culture into 2 mL LB medium 
(supplemented with 55 μg/mL of kanamycin) for further incubation at 37°C with shaking at 220 
rpm for 4 hours. We transferred 20 μL of the culture into 200 μL LB medium (55 μg/mL of 
kanamycin) in a Thermo Scientific Nunc Edge 2.0 96-well plate (to minimize evaporation), and 
incubated it in a Tecan Infinite F200 microplate reader at 37°C (2 mm orbital shaking), until the 
culture had reached an OD600 of ~0.6 (optical path length: 1 cm). Subsequently, we added 4 μL 
of 10% arabinose to induce YFP expression, and continued the incubation for 16 hours at 37°C. 
After these 16 hours, we sampled the culture for fluorescence assays using flow cytometry and 
fluorescence emission scanning with a Tecan microplate reader. To induce the expression of 
YFP variants in engineered variants, we followed the same procedure, except that we incubated 
them in a microplate incubator at 800 rpm (To prevent evaporation, we sealed plates using 
Parafilm and removed it after 15 hours of incubation, and then continued the incubation for one 
hour). 
Fluorescence assay using flow cytometry 
Sixteen hours after induction of expression, we suspended a 40 μL sample of the culture in 
160 μL of cold PBS buffer, transferred 20 μL of the suspension to 180 μL cold PBS buffer, and 
mixed thoroughly to measure yellow fluorescence at the original wavelength (λex=488nm and 
λem=530±15nm) and green fluorescence at the new wavelength (λex=405nm and λem=525±25nm) 
using flow cytometry. We performed the cytometry assay at room temperature using a Fortessa 
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cell analyzer (BD Biosciences) with a flow rate of ~3000 events/s. We performed three 
biological replicates for each assay and analyzed 104 cells for each replicate. We placed all 
samples on ice until we had finished the assay to prevent cell proliferation or death. 
Fluorescence emission scan 
To measure the emission spectrum of evolving populations in each generation of evolution, 
we sampled 40 μL of culture after 16 hours of expression induction, suspended the sample in 160 
μL of cold PBS buffer, and mixed thoroughly. Subsequently, we measured fluorescence (i) at the 
excitation wavelength λex=485nm for emission wavelengths varying between 520 nm and 560 
nm, and (ii) at the excitation wavelength λex=405 nm for emission wavelengths varying between 
438 nm and 560 nm in a Tecan Infinite F200 microplate reader. We performed this fluorescence 
emission scan at room temperature (24-27°C) in 2 or 3 nm increments. 
Flow Cytometry Data Analysis 
We used FlowJo V10.4.2 (LLC) to perform flow cytometry data analysis. In brief, we used 
forward scatter height (FSC-H) versus side scatter height (SSC-H) density plots to select a 
homogenous cell population, and used side scatter area (SSC-A) versus side scatter height (SSC-
H) density plots to exclude doublets. Finally, we used FITC-Height versus AmCyan-Height 
density plots to further exclude dust, cellular debris and micro-particles (see the details in Fig. 
S8). We used the resulting filtered data for calculating the mean fluorescence intensity of each 
biological replicate.  
SMRT sequencing  
We barcoded YFP variants of each replicate population for single molecule real-time 
(SMRT) sequencing using two-step PCRs, as described previously (60). We performed PCR 
amplification using high-fidelity Phusion DNA polymerase to decrease the incidence of 
mutations during this process. Briefly, we first performed a 12-cycle PCR to amplify YFP 
variants from each replicate population using primers FP_smrtF/pBAD849R (Table S11) in a 30 
µL PCR reaction, consisting of 1 ng template plasmid, 400 nM of each primer, 400 µM dNTPs, 
6 µL 5× Phusion HF Buffer, 0.3 µL 100% DMSO and 1.5 U Phusion Hot Start II High-Fidelity 
DNA Polymerase (F-549L, Thermo Scientific). We executed the PCR reaction with the 
following thermocycler program: 98°C/30 s, 12 cycles of 98°C/15 s, 65°C/15 s and 72°C/15 s, 
72°C/1 min. We treated the above PCR product with 5 U DpnI and 5 U Exonuclease I (EN0581, 
Fermentas) at 37°C for 1 h to digest the template plasmid and the primers, and inactivated these 
enzymes at 85°C for 20 min. Then we used the resulting product as template for a barcoding 
PCR using the barcode-tagged primers BCXX and pBAD849R (Table S11). Each barcode-
tagged primer harbors a unique 6 bp sequence. We performed the barcoding PCR in a 50 µL 
volume by mixing 2 µL of template, 400 nM primers BCXX and pBAD849r, 400 µM dNTPs, 
2.5 U of Phusion Hot Start II High-Fidelity DNA Polymerase, and 10 µL of 5× Phusion HF 
Buffer. We executed the PCR amplification with the following thermocycler program: 98°C/30 
s; 28 cycles of 98°C/15 s, 63°C/15 s and 72°C/15 s; 72°C/1 min.  
We puriﬁed the barcode-tagged PCR products with a QIAquick PCR puriﬁcation kit, and 
checked their quality and concentration using a UV-Vis spectrophotometer (NanoDrop, Thermo 
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Fisher Scientific), a Qubit 4 Fluorometer (Invitrogen), and agarose gel electrophoresis. To 
estimate potential errors that might occur during library preparation, we used the same procedure 
to amplify the ancestral YFP gene. After that, we pooled 20 ng DNA of each population from the 
same generation of evolution in a single test tube (eight pooled samples in total for our eight 
generations of evolution). We constructed the SMRTbell library using the DNA Template Prep 
Kit 2.0 (250 bp - 3 Kb, Paciﬁc Biosciences). We ligated a blunt end adapter that contains a 
unique 16-bp barcode (Table S12) to amplicons of each sample, and used the ligation products as 
SMRTbell templates. We used the DNA/Polymerase P4 binding kit (Paciﬁc Biosciences) to 
create ready-to-sequence SMRTbell-polymerase complexes, and pooled these complexes to 
create one amplicon pool. Subsequently, we sequenced this amplicon pool on eight SMRT cells 
(v3.0) using the Paciﬁc Biosciences RS2 instrument (Paciﬁc Biosciences). We used P4/C2 
chemistry and the magnetic bead loading method, and recorded two movies of 3 hour duration 
for each cell. 
Primary Data Analysis  
We analyzed SMRT sequencing data using a previously described pipeline (60). Briefly, we 
used the protocol RT_ReadsOfInsert in SMRTAnalysis v2.3 package to demultiplex the PacBio 
RSII raw data and assemble consensus reads from sub-reads (61). We set the full-pass subread 
number to ≥4, the insert length to 650-1000 bp, and the predicted consensus accuracy to ≥0.9, in 
order to ﬁlter reads of YFP inserts. We set a minimum barcode score of 23 (resulting in 99.5% 
calling accuracy) to demultiplex the resulting consensus reads from the same generation of 
evolution into a single file. We mapped reads from each single file to the ancestral YFP sequence 
(58) using BLASR (62) by setting the mapped length to ≥850 bp and the mapping accuracy to 
≥0.9. We only used mapped reads that span the entire YFP coding region and that had an average 
Phred quality above 20 for further analysis. We used SAMtools (63) for converting the resulting 
sam files to bam files, and de-multiplexed the filtered, mapped reads according to each read’s 
barcode using custom Python scripts. We excluded those sequences from further analysis that 
lacked a start codon or stop codon. These primary processing steps yielded hundreds of 
sequences from each replicate population for further analyses (Table S4).  
Identification of SNPs and mutation combinations 
Because single-nucleotide indels account for more than 90% of sequencing errors during 
SMRT sequencing (64), and because most indels render YFP non-functional, we ignored indels 
and only analyzed point mutations. A mismatch of an YFP variant sequence to the YFP reference 
sequence was considered a true SNP (point mutation) only if its Phred quality score was above 
20. We wrote Python scripts (Python 2.7.12) to identify point mutations and their combinations, 
and calculated their frequencies in each replicate population from each generation of evolution. 
Because we genotyped 613-1574 variants for each replicate population and in each phase I 
generation, our detection limit for SNPs or mutation combinations varied with the reciprocal of 
these values between 0.064% to 0.163%, depending on the population and generation. 
Calculation of genetic diversity within populations  
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We used the pairwise alignment positional nucleotide counting (PAPNC) method (65) for 
calculating the per-site and average genetic diversity, as described previously (60). We used 
Python 2.7.12 to compute sequence identity and similarity from sequence alignments. 
Calculation of the mean distances between populations 
We determined the mean genetic distance between all pairs of sequences whose members are 
taken from two different populations at the evolutionary end point. To this end, we used 
MEGAX 10.0.5 (https://www.megasoftware.net/) to calculate the number of amino acids that 
differed between two sequences, and averaged these differences for all pairs of sequences in the 
two populations.  
Creation of genotype networks  
To create the networks shown in Fig. 3C, we determined the set of amino acid sequences 
(genotypes) that appeared in at least one generation of at least one replicate population. A 
genotype consisted of the amino acid residues at those fifteen positions in a fluorescent protein 
sequence (positions 2, 43, 47, 65, 66, 72, 102, 129, 141, 145, 164, 167, 168, 172 and 204) where 
four typical mutations, eleven alternative mutations, two expression-improving mutations (see 
Supplementary Text S1) and the mutation L43M arose. We represented each genotype as a 
vertex in the network and connected two vertices by an edge if their corresponding sequences 
differed by a single amino acid. The layout of the network was generated with a force-directed 
algorithm (“force atlas 2”) in Gephi (https://gephi.org/). 
Statistical analysis 
Unless specified otherwise, we used a two-tailed t-test to conduct pairwise comparisons or 
multiple comparisons with Holm adjustment to control the family-wise error rate. To test the 
statistical significance of the fluorescence intensity change caused by every single mutation at 
different genetic backgrounds, we performed a two-sided t-test with Holm corrections. To 
determine whether each VC replicate population had significantly higher green fluorescence 
increase than all V0 populations at the evolutionary endpoint, we performed a two-way ANOVA 
with post hoc Tukey’s test. We performed all statistical analysis using R version 3.4.4. 
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Supplementary Text 
Supplementary Text S1 Expression-improving mutations were enriched during evolution 
for green fluorescence 
During evolution for green fluorescence, several mutations located at the N-terminus of the 
protein achieved high or medium frequency in both V0 and VC populations (the first twenty 
residues, Fig. S3). For example, the mutations V2A and V2M (the latter change forms two 
consecutive start codons) reached a frequency of more than 10% in most replicate populations of 
V0 and VC. We engineered these two mutations into the ancestral YFP and measured their effects 
on both yellow fluorescence and green fluorescence. They can improve both yellow fluorescence 
and green fluorescence by a similar amount (Fig. S9A). Also, they can improve green 
fluorescence by almost the same amount in the genetic backgrounds G66S, Y204C and 
G66S+Y204C (Fig. S9A). Based on the above observations, we suspect that they affect 
fluorescent protein expression. Notably, these mutations did not attain significantly higher 
frequency in VC populations than in V0 populations (Fig. S9B). Thus, these mutations are not 
main contributors to faster phenotypic and genetic evolution in VC populations. However, the 
modest increase in yellow fluorescence after the first generation of phase II could be caused by 
the accumulation of these expression-improving mutations (Fig. 2A). 
Supplementary Text S2 Sign epistasis constrains the accessibility of mutational paths to 
high-fitness genotypes in V0 populations 
Although each of the eleven alternative mutations and the typical mutation F47L do not 
improve green fluorescence individually (Fig. S10), these mutations or combinations thereof can 
significantly enhance green fluorescence when they co-occur with the typical mutations G66S 
and Y204C (Fig. S10 & Fig. 3E). Such epistatic interactions can constrain the mutation paths to 
high-fitness genotypes in V0 populations. To find out whether this is the case, we engineered 
selected mutations and their combinations described below into ancestral YFP and measured 
their fluorescence.   
We first analyzed the accessibility of mutational paths leading to the typical genotype T1 
(T+F65L), by measuring fluorescence of all eight genotypes leading to this genotype. Five of six 
mutational paths are accessible (Fig. 4A). In contrast, the same approach shows that only two 
and three of six potential paths to the typical genotype T2 (T+F47L) and T3 (T+L43M) are 
accessible, respectively (Fig. S5).  
We next analyzed the alternative genotype A1 (Fig. 4A & Fig. S5), and noted that none of 
the four individual mutations that constitute it (F65S, K102R, N145S and V164A) can 
significantly improve green florescence in the genetic background of T or in the ancestral YFP. 
Thus, there is no accessible path to this genotype.  
For the alternative genotype A2 (T+F72I+I172V+K167E; Fig. S6 & S10), F72I, I172V, or 
K167E do not significantly improve green florescence in the genetic backgrounds of G66S, 
Y204C or ancestral YFP. However, F72I or I172V can significantly improve green florescence 
in the T background, whereas K167E can significantly improve green florescence in the 
T+F72I+I172V background. These measurements lead us to conclude that only four out of one 
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hundred and twenty possible mutational paths to this alternative genotype are accessible from the 
wild-type.  
For the alternative genotype A3 (T+F47L+I129T+K141R), we engineered mutations I129T 
and K141R individually into the background of T, and found that these mutations individually do 
not improve green fluorescence (Fig. S5 & S10). An analogous experiment shows that the joint 
mutation I129T+K141R slightly improves green florescence by 6.4% in background T2 
(T+F47L), but significantly increases green florescence by 14.6% in the background of T2+V2M 
(Fig. S11). Thus, the joint mutation I129T+K141R is slightly beneficial in background T2, but 
more strongly beneficial in the presence of the additional mutation V2M, which can improve 
fluorescent protein expression (Fig. S9). These observations are also consistent with the 
observation that 95.61% of A3 genotypes also harbor the mutation V2M at the evolutionary 
endpoint (Fig. S11). To simplify the analysis of accessibility of mutation paths to A3, we do not 
consider the effect of V2M and treat the joint mutation I129T+K141R as a beneficial mutation in 
background T2. Although we did not engineer I129T and K141R individually into the 
background of T2, the following considerations allow us to assert that no more than 8.33% of 
paths to A3 are accessible. First, if neither I129T nor K141R separately can significantly 
improve green florescence in background T2, no path would be accessible to genotype A3 from 
T2 (0% accessible paths). Second, if only one of the two mutations I129T and K141R were to 
improve green florescence in background T2, then only two of twenty-four possible paths to 
T2+I129T or T2+K141R would be accessible (8.33% accessible paths), because either I129T or 
K141R would not contribute to green fluorescence of A3. Lastly, if I129T or K141R separately 
can significantly improve green florescence in background T2, it follows from our measurements 
that no more than four out of one hundred and twenty paths (3.33%) to A3 can be accessible.  
For the alternative genotype A4 (T+F72C+I168V), we engineered and measured thirteen 
genotypes leading to this genotype. These measurements show that I168V cannot increase green 
fluorescence in the background T+F72C (Fig. S12). However, it compensates for the deleterious 
effects of the mutations G66S, T and T+F72C on yellow fluorescence (Fig. S12). It is thus likely 
that I168V already occurred in phase I to compensate the deleterious effects of mutations G66S, 
Y204C, F72C (or combinations thereof). For this reason, it would be inappropriate to include 
I168V when constructing potential mutational paths to the alternative genotype A4 based on its 
effects on green fluorescence. Of the remaining six paths to T+F72C, two are accessible (Fig. 
S5). 
Supplementary Text S3 Evolutionary trajectories of high-fitness genotypes in V0 and VC 
populations 
Our experimental data on (i) genotype frequency (Table S6, S13-24) and (ii) the rate at 
which mutation pressure alone causes specific mutations to increase in frequency during 
evolution enabled us to infer the evolutionary trajectories of high-fitness genotypes in each 
replicate population. Consider this example for typical genotype T1 in replicate population 01V . 
Genotype T1 first appeared during the third generation (Table S13). In the second generation, we 
detected the three constituent mutations of this genotype individually at frequencies of 0.16% 
(F65L), 2.17% (Y204C), and 62.95% (G66S), as well as two out of the three possible double 
mutants at frequencies 0.16% (G66S+F65L) and 11.32% (G66S+Y204C, which is the T 
genotype). From our evolution experiments in the absence of selection (Fig. S4), we can quantify 
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how fast individual mutations and genotypes are expected to arise through mutation pressure 
alone (Table S7). From this experimental data, we can compute the probability P of each 
possible mutational path (or genotype) leading to T1 as shown below, where fX indicates the 
observed frequency of mutation X in the second generation, and µX indicates the rate at which a 
mutation X arises in the absence of selection, i.e., through mutation alone.  
PF65L→T1 = fF65L×µY204C×µG66S=0.16%× 0.258%×0.0868%=3.6×10-9 
PY204C→T1 = fY204C×µF65L×µG66S=2.17%×0.22%×0.0868%=4.1×10-8 
PG66S→T1 = fG66S×µY204C×µF65L=62.95%×0.258%×0.22%=3.6×10-6 
PG66S+F65L→T1 = fG66S+F65L×µY204C =0.16%×0.258%=4.1×10-6 
PT→T1 = fT×µF65L=11.32%×0.22%=2.5×10-4 
Note that these calculations allow simultaneous appearance of two but not of three 
mutations because the simultaneous occurrence of three mutations is very unlikely (<10-7, 
estimated by raising the mean incidence rates of mutations in Table S7 to the third power). The 
above computation shows that the most likely mutational path to reach T1 starts from T because 
its probability (PT→T1) is much higher than all others. Next, we used the same approach to 
estimate the possible mutational paths (or genotypes) leading to T itself, which showed that T 
would most likely first appear at a frequency of 0.45% in the first generation, which involves the 
ancestor acquiring two mutations at once. Taken together, these analyses show that the most 
likely evolutionary trajectory leading to T1 in Vଵ଴ reaches it from the wild-type ancestor via 
genotype T in two steps (WT→T→T1; Fig. S7). 
Using the above strategy, we inferred the most likely paths to all typical and alternative 
genotypes in each replicate population. Fig. S7 summarizes these analyses and shows that all the 
typical genotypes, which dominate V0 populations, are most likely reached by selectively 
accessible trajectories. In contrast, all except one of the high-fitness genotypes in VC populations 
(T1 in C2V ), are reached by trajectories that would be inaccessible to V
0 populations. Thus, the 
cryptic variation that accumulated during phase I evolution is important to reach otherwise 
unattainable high fitness genotypes.   
  
 
 
13 
 
 
 
Fig. S1. 
The emission spectrum of ancestral YFP at the native excitation wavelength (yellow line, 
λex=488nm) and at the phase II excitation wavelength (green line, λex=405nm). The vertical 
axis indicates fluorescence intensity (arbitrary units) at the emission wavelength (horizontal 
axis).  
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Fig. S2. 
(A) Rate of evolutionary adaptation (shown as the increase of green fluorescence intensity 
in each generation) of populations V0 and VC during phase II evolution. Each circle 
represents a replicate population. We performed two-sided t-tests to determine whether the 
adaptation rates between V0 and VC are significantly different in each generation. **indicates 
P<0.01. (B) Distribution of the number of amino acid changing mutations per individual 
molecule in V0 and VC populations during the phase II evolution. Each circle represents the 
mean of four replicate populations. Lines were generated by LOESS curve fitting. Thin lines 
represent the frequency distribution from generation 1 to 3, and thick lines indicate the frequency 
distribution at the end of phase II (generation 4). To count the number of amino acid changing 
mutations per sequence, we aligned each individual amino acid sequence inferred from DNA 
sequences of each population to the ancestral YFP reference sequence. (C) Average pairwise 
sequence distance (see Materials and Methods) of evolving V0 (thick blue lines) and VC 
(thick red lines) populations. Error bars represent one SEM of four replicate populations. Each 
thin blue and red line represents a replicate population of V0 and VC, respectively. We performed 
one-sided t-tests to determine if the genetic diversity of the VC populations was higher than the 
genetic diversity of the V0 populations (t=-70.43, df=5.26, P=2.46×10-9 for generation II-1, t=-
12.04, df=3.37, P=0.00035 for generation II-2, t=-3.29, df=3.11 and P=0.022 for generation II-3 
and t=-1.69, df=3.02 and P=0.094 for generation II-4). *, *** and **** indicate P<0.05, 0.001 
and 0.0001. (D) Average number of amino-acid differences (at the evolutionary endpoint) 
between all protein sequences in the labeled populations (see Materials and Methods). (E) 
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The frequency of genotypes in each replicate V0 and VC population at the endpoint of 
evolution. Estimates of the frequency of A1 and A2 also include genotypes derived from A1 or 
A2 but with one fewer mutation (see Table S5). 
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Fig. S3.  
Dynamics of amino acid changing single nucleotide polymorphism (SNP) frequencies in 
evolving populations V0 and VC during the evolution of green fluorescence (phase II).  
(A) The horizontal axis indicates time (generations of directed evolution), and the vertical axis 
indicates individual mutations. Colored squares indicate mutation frequencies (see color legend). 
Only those SNPs which achieved a frequency exceeding 10% in at least one replicate population 
of V0 and VC are shown. (B) The horizontal axis indicates time (generations of directed 
evolution), and the vertical axis indicates the frequencies of individual mutations. Thick blue and 
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red lines indicate averages for populations V0 and VC, respectively, and error bars represent one 
SEM based on four replicate populations. Each thin blue or red line indicates data from a single 
replicate population V0 or VC, respectively. For each generation, we performed two-sided t-tests 
to determine whether the frequencies of individual mutations differed between V0 and VC. ‘*’ 
indicates P<0.05.  
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Fig. S4.  
Most mutations that reach appreciable frequency in phase I do not accumulate at rates 
greater than expected from the mutation rate alone. The populations Nsel1-4 (No selection) 
underwent the same directed evolution protocol as populations VC, except that we collected all 
gene variants encoding fluorescent protein in each generation, regardless of the fluorescence 
intensity of the encoded proteins. In other words, populations Nsel1-4 did not experience selection 
for yellow fluorescence, and thus serve as controls to identify candidate mutations influenced by 
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selection in VC populations, because they increase more rapidly in frequency in VC populations 
than in Nsel populations. In panel A, the horizontal axes indicate time (generations of directed 
evolution), and the vertical axis lists individual mutations. The color scale indicates mutation 
frequency. In panel B, the horizontal axes indicate time (in generations of directed evolution), 
and the vertical axes indicate mutation frequency. Each grey or blue circle represents frequency 
data from a replicate VC or Nsel population, respectively. Error bars represent one SEM over four 
replicate populations. We used F-statistics to determine whether increases in mutant frequencies 
are significantly different from zero, as indicated by the p-values shown in grey for Nsel 
populations and in red for VC populations. Values of r2 indicate the proportion of variance 
explained by each regression. Importantly, we also conducted two-way Ancovas with Holm 
adjustment to compare the two linear regression models for each mutation, which are generated 
based on the frequency data of each mutation from VC or Nsel populations in phase I, 
respectively. The resulting P values are highlighted in boxes (Padj). This analysis showed that 
only the F47L mutation frequency increased faster than expected from the mutation rate alone 
during stabilizing selection for yellow fluorescence in phase I.  
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Fig. S5.  
Accessible and inaccessible mutational paths to typical and alternative high fluorescence 
genotypes. We distinguish three kinds of steps in a mutational path, an accessible mutational 
step (blue arrows) that increases green fluorescence significantly, an inaccessible step (dashed 
red arrows) that does not increase green fluorescence significantly, and a conditionally accessible 
step (solid red arrows) that increases green fluorescence significantly in the genetic background 
where it occurs, but where the ancestral YFP must first traverse one or more inaccessible steps to 
create this genetic background. Blue circles indicate genotypes created by an accessible step, 
whereas red circles indicate genotypes created by an inaccessible or a conditionally accessible 
step. A path is inaccessible if it contains at least one inaccessible step. To determine 
accessibility, we considered a difference in green fluorescence between genotypes significant 
only if P<0.05, based on a two-sided t-test with Holm adjustment. For this test, we performed 
three biological replicate fluorescence measurements, and analyzed 104 cells for each biological 
replicate. The numbers of accessible paths and total paths are shown in each panel. 
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Fig. S6.  
Accessibility of mutational paths to the alternative genotype A2 (see also Supplementary 
Text S2). Blue lines indicate an accessible mutational step, which increases green fluorescence 
significantly, and dashed red lines indicate an inaccessible step, which does not significantly 
increase green fluorescence. Solid red lines indicate a conditionally accessible step that 
significantly increases green fluorescence in the genetic background where it occurs, but where 
the ancestral YFP must first experience one or more inaccessible steps to create this kind of 
genetic background. A path is inaccessible if it contains at least one inaccessible step. We 
considered a difference in green fluorescence between genotypes as significant if P<0.05 (Two-
sided t-test with Holm adjustment).  
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Fig. S7.  
Inferred evolutionary trajectories of typical and alternative high fluorescence genotypes in 
V0 or VC populations. We inferred the mutational paths to typical and alternative high 
fluorescence genotypes based on frequency data of genotypes in each population and on the 
incidence of mutations during evolution (see Supplementary Text S3). The horizontal axis 
indicates time (generation). The vertical axes indicate individual replicate populations (V0 or VC) 
and the trajectories of high fitness genotypes that attain high frequency in these populations. 
Circle area reflects the frequency of the genotype that labels the circle. ‘X’ indicates a genotype 
that is likely to exist but that cannot be detected, and it was given the minimum circle area, 
because its frequency is below the detection limit (See Materials and Methods). Solid and dashed 
arrows indicate selectively accessible and inaccessible paths, respectively. A path is inaccessible 
if it contains at least one inaccessible step (See Fig. S5 and Supplementary Text S2 for details). 
The figure shows that all three typical genotypes attained by V0 populations evolve by following 
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selectively accessible trajectories, whereas all alternative high-fitness genotypes (except one 
typical genotype T1 in C2V ) evolved in V
C populations by following trajectories that would be 
selectively inaccessible in V0 populations (see Supplementary Text S2 for details). 
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Fig. S8.  
Representative gates for flow cytometry data analysis. We used forward scatter height (FSC-
H) versus side scatter height (SSC-H) density plots to select a homogenous cell population (p1 in 
panel A), and used side scatter area (SSC-A) versus side scatter height (SSC-H) density plots to 
exclude doublets (p2 in panel B). For each evolving replicate population, we used FITC-Height 
(FITC-H) versus AmCyan-Height (AmCyan-H) density plots to further exclude dust, cellular 
debris and micro-particles, which showed fluorescence characteristic of the negative control 
population (ancestral YFP without adding arabinose for YFP induction; p3 in panel C). For each 
engineered variant, we used FITC-Height versus AmCyan-Height density plots to select the 
dominant cell population (p4 in panel D). We used the resulting filtered data (p3 or p4) for 
calculating the mean fluorescence intensity of each biological replicate.  
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Fig. S9.  
(A) Effects of mutations V2A and V2M on yellow fluorescence and green fluorescence. 
The horizontal axis indicates genotypes V2A and V2M, and the vertical axis indicates yellow 
and green fluorescence intensity, expressed as a fold-change relative to ancestral YFP at different 
genetic backgrounds. Error bars represent one standard deviation of three biological replicate 
fluorescence measurements. We analyzed 104 cells for each such replicate. We performed two-
sided t-tests (P-values shown above bars) to determine whether green and yellow fluorescence 
intensities differed significantly. (B) Frequency of V2A and V2M in evolving population V0 
and VC during the evolution of green fluorescence. Thick blue and red lines indicate means 
for populations V0 and VC, respectively, and error bars represent one SEM of four replicate 
populations. Each thin blue and red line indicates data from a replicate population of V0 and VC, 
respectively. We performed two-sided t-test to determine the statistical significance of frequency 
differences in V2A or V2M between V0 and VC in each generation of evolution. *, ** or *** 
indicate that P<0.05, 0.01 or 0.001 respectively.   
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Fig. S10.  
Effects of single mutations on green fluorescence in different genetic backgrounds.  
The left vertical axes indicate the fluorescence intensity change of each mutation (horizontal 
axes) in different genetic backgrounds (right vertical axes) relative to proteins with that genetic 
background, i.e., lacking the mutation. Error bars represent one standard deviation and are based 
on three or six biological replicate measurements. We analyzed 104 cells for each biological 
replicate. Each dot represents a biological replicate measurement. We performed two-sided t-test 
with Holm adjustment to test the null hypothesis that the fluorescence intensity of a given mutant 
is identical to that of the background. *, ** and *** indicate P<0.05, 0.01 and 0.001.  
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Fig. S11.  
The beneficial effect of the joint mutation I129T+K141R becomes pronounced in 
background T2+V2M. Panel A shows the relative fluorescence intensity of each indicated 
genotype (horizontal axis) relative to the ancestral YFP. Error bars represent one standard 
deviation and are based on six biological replicate measurements. We analyzed 104 cells for each 
biological replicate. Each dot represents a biological replicate measurement. We performed two-
sided t-tests (P-values shown above bars) to determine whether the green fluorescence intensities 
between T2 and A3 or between T2+V2M and A3+V2M differed significantly. Panel B shows the 
frequency of two genotypes in the population 3
CV during Phase II, as well as the ratio r of the 
frequency of A3+V2M to the frequency of A3 (dashed line).  
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Fig. S12.  
Effects of the mutation I168V on yellow (A) and green (B) fluorescence in different genetic 
backgrounds. The horizontal axis indicates genotypes, and the vertical axis indicates the 
fluorescence intensity change caused by the acquisition of the mutation I168V by the 
corresponding genotypes. Error bars represent one standard deviation based on three biological 
replicate fluorescence measurements, and on 104 analyzed cells for each such replicate. Each 
green or yellow dot represents a biological replicate measurement. We performed two-sided t-
test with Holm adjustment to test the null hypothesis that the fluorescence intensity after 
acquiring the mutation I168V did not significantly change. P values are shown above the bars. *, 
** and *** indicate P<0.05, 0.01 and 0.001.  
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Table S1  
Mean number of SNPs per YFP molecule for evolving YFP populations during each generation 
of mutagenesis as determined by SMRT sequencing. 
Population 
SNPs per read in each generation of mutagenesis 
I-1 I-2 I-3 I-4 II-1 II-2 II-3 II-4 
0
1V      2 3.19 4.8 5.87 
0
2V      1.98 3.18 4.85 6.05 
0
3V      1.96 3.18 4.61 6.2 
0
4V      1.88 3.27 4.71 6.05 
1
CV  1.19 2.13 2.97 4.19 5.28 6.22 7.52 8.34 
2
CV  1.23 2.24 2.98 4.19 5.22 6.3 7.57 8.87 
3
CV  1.22 1.96 2.73 3.84 5.08 8.15 10.42 11.06 
C
4V  1.19 2.09 2.81 3.92 5.33 6.28 7.31 8.04 
Nsel1 1.21 3.32 5 6.04     
Nsel2 1.31 3.22 4.54 5.65     
Nsel3 1.23 3.21 4.62 6.04     
Nsel4 1.15 3.3 4.9 6.18     
Control 1a 1.04        
Control 2a 1.05        
YFP(ancestor)b 0.03        
YFP(ancestor)b 0.04        a After constructing the mutation library, we sequenced the library before selection to estimate the mutation rate. 
b We used ancestral YFP as a control and sequenced its encoding gene (see Materials and Methods). 
We subjected populations Nsel1-4 to the same procedure as populations VC but without selection, i.e., we collected all 
generated variants in each generation, regardless of their fluorescence intensity. 
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Table S2  
Mean number of amino-acid changes per YFP molecule for evolving YFP populations during 
each generation of mutagenesis as determined by SMRT sequencing. 
Population 
Amino-acid changing mutation per read for each generation of mutagenesis 
I-1 I-2 I-3 I-4 II-1 II-2 II-3 II-4 
Vଵ଴     1.42 2.70 4.05 4.74 
Vଶ଴     1.45 2.59 4.10 5.09 
Vଷ଴     1.40 2.48 3.80 5.09 
Vସ଴     1.37 2.75 4.15 5.46 
Vଵେ 0.95 1.59 2.19 3.03 3.86 5.07 6.35 6.90 
Vଶେ 0.98 1.71 2.13 2.98 3.70 4.44 5.63 6.78 
Vଷେ 0.96 1.48 2.00 2.80 3.74 5.66 6.91 7.45 
Vସେ 0.96 1.62 2.10 2.90 3.64 4.39 4.98 5.49 
Nsel1 0.98 2.64 4.02 4.89     
Nsel2 1.02 2.55 3.66 4.57     
Nsel3 0.97 2.58 3.72 4.90     
Nsel4 0.92 2.64 3.99 4.94     
Control 1a 0.83        
Control 2a 0.84        
YFP(ancestor)b 0.028        
YFP(ancestor)b 0.025        a After constructing the mutation library, we sequenced the library before selection to estimate the mutation rate. 
b We used ancestral YFP as a control and sequenced its encoding gene (see Materials and Methods). 
We subjected populations Nsel1-4 to the same procedure as populations VC but without selection, i.e., we collected all 
generated variants in each generation, regardless of their fluorescence intensity.  
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TableS 3  
Statistical significance of green fluorescence fold change between each replicate population of 
V0 and VC at the evolutionary endpoint a 
Population diff 
b lwr c upr d P value (padj) e 
Vଷେ-Vସେ -40.729 -58.328 -23.13 1.2E-05 
Vଶେ-Vସେ -34.136 -51.736 -16.537 0.00011 
Vଵେ-Vସେ -28.447 -46.046 -10.848 0.00082 
𝐕𝟒𝟎-𝐕𝟒𝐂 -72.574 -90.173 -54.975 0 
𝐕𝟑𝟎-𝐕𝟒𝐂 -53.061 -70.66 -35.462 3E-07 
𝐕𝟐𝟎-𝐕𝟒𝐂 -68.408 -86.007 -50.809 0 
𝐕𝟏𝟎-𝐕𝟒𝐂 -63.887 -81.486 -46.288 0 
Vଶେ-Vଷେ 6.59228 -11.007 24.1914 0.88732 
Vଵେ-Vଷେ 12.2821 -5.317 29.8812 0.29703 
𝐕𝟒𝟎-𝐕𝟑𝐂 -31.845 -49.444 -14.246 0.00024 
𝐕𝟑𝟎-𝐕𝟑𝐂 -12.332 -29.931 5.2668 0.29279 
𝐕𝟐𝟎-𝐕𝟑𝐂 -27.679 -45.278 -10.08 0.00109 
𝐕𝟏𝟎-𝐕𝟑𝐂 -23.158 -40.758 -5.5594 0.00606 
Vଵେ-Vଶେ 5.68983 -11.909 23.2889 0.94297 
𝐕𝟒𝟎-𝐕𝟐𝐂 -38.437 -56.036 -20.838 2.5E-05 
𝐕𝟑𝟎-𝐕𝟐𝐂 -18.925 -36.524 -1.3255 0.03051 
𝐕𝟐𝟎-𝐕𝟐𝐂 -34.271 -51.87 -16.672 0.0001 
𝐕𝟏𝟎-𝐕𝟐𝐂 -29.751 -47.35 -12.152 0.00051 
𝐕𝟒𝟎-𝐕𝟏𝐂 -44.127 -61.726 -26.528 4.3E-06 
𝐕𝟑𝟎-𝐕𝟏𝐂 -24.614 -42.213 -7.0153 0.00347 
𝐕𝟐𝟎-𝐕𝟏𝐂 -39.961 -57.56 -22.362 1.5E-05 
𝐕𝟏𝟎-𝐕𝟏𝐂 -35.441 -53.04 -17.842 6.8E-05 
Vଷ଴-Vସ଴ 19.5126 1.91356 37.1117 0.02443 
Vଶ଴-Vସ଴ 4.1661 -13.433 21.7652 0.98925 
Vଵ଴-Vସ଴ 8.68646 -8.9126 26.2855 0.6824 
Vଶ଴-Vଷ଴ -15.347 -32.946 2.25254 0.11192 
Vଵ଴-Vଷ଴ -10.826 -28.425 6.7729 0.43768 
Vଵ଴-Vଶ଴ 4.52036 -13.079 22.1194 0.98293 
a we performed two-way ANOVAs with post hoc Tukey’s test (F7,16=46.5, P=1.99×10-9). The comparisons between 
VC and V0 replicate populations are highlighted in bold. 
b diff refers to the difference in the observed means. 
c lwr refers to the lower end point of the confidence interval.   
d upr refers to the upper end point of the confidence interval.   
e padj refers to the p-value after adjustment for the multiple comparisons.   
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Table S4  
Number of reads sequenced by SMRT sequencing for evolving YFP populations during each 
generation of evolution 
Population 
Reads in each generation 
I-1 I-2 I-3 I-4 II-1 II-2 II-3 II-4 
Vଵ଴     894 645 586 631 
Vଶ଴     922 709 592 798 
Vଷ଴     1002 593 607 460 
Vସ଴     835 745 569 220 
Vଵେ 630 1226 1084 1389 898 826 651 753 
Vଶେ 808 613 939 827 833 643 542 553 
Vଷେ 928 1045 1571 1382 925 589 764 524 
Vସେ 1172 1081 1250 879 861 778 599 585 
Nsel1 1011 947 659 764     
Nsel2 749 1290 810 929     
Nsel3 795 872 744 787     
Nsel4 521 700 862 677     
Control 1a 1764        
Control 2a 1188        
YFP(ancestor)b 910        
YFP(ancestor)b 629        a after constructing the mutation library, we sequenced the library before selection to estimate the mutation rate. 
b We used ancestral YFP as a control and sequenced its encoding gene (see Materials and Methods). 
We subjected populations Nsel1-4 to the same procedure as populations VC but without selection, i.e., we collected all 
generated variants in each generation, regardless of their fluorescence intensity. 
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Table S5  
Green fluorescence intensity of four alternative genotypes and their frequency at the endpoint of 
evolution 
Genotype Mutation Frequency (%) Population Green fluorescence intensity a 
A1 
T+F65S+K102R+N145S+V164A 12.9 
Vଵେ 
47.4±4.8 
T+F65S+N145S+V164A 4.9 52.8±6.3 
A2 
T+F72I+K167E+I172V 6.8 
Vଵେ 
52.5±0.4  
T+F72I+I172V 1.5 44.0±1.2 
T+F72I+K167E 2 29.4±0.5 
T+K167E+I172V 5.4 18.4±1.3  
A3 T+F47L+I129T+K141R 56.5 Vଷେ 33.5±1.2 
A4 T+F72C+I168V 82.7 Vସେ 49.6±1.2  
a expressed as a fold-change relative to ancestral YFP 
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Table S6  
Frequency of genotypes leading to A4 in C4V  during evolution 
Mutation     Generation     
G66S Y204C F72C I168V I-4 II-1 II-2 II-3 II-4 
- - - - 97.27 50.52 14.52 5.01 1.03 
- - - + 1.48 1.05 0.39 0.00 0.17 
- - + - 0.23 0.12 1.93 1.17 0.17 
- - + + 0.00 0.00 0.13 0.17 0.00 
- + - - 0.46 6.50 2.96 1.67 0.00 
- + - + 0.00 0.00 0.64 0.50 0.34 
- + + - 0.00 0.12 2.19 0.67 0.34 
- + + + 0.00 0.12 0.00 0.50 0.51 
+ - - - 0.57 38.10 18.51 3.67 1.71 
+ - - + 0.00 1.05 0.64 0.50 0.34 
+ - + - 0.00 0.12 5.14 3.17 1.88 
+ - + + 0.00 0.00 1.29 2.17 1.71 
+ + - - 0.00 2.32 12.85 4.67 2.05 
+ + - + 0.00 0.00 2.31 2.17 1.88 
+ + + - 0.00 0.00 8.87 8.18 5.13 
+ + + + 0.00 0.00 27.63 65.78 82.74 
Note that the data in green indicate the inferred trajectories with highest probability (see Supplementary Text S3), 
and the data in yellow indicate the frequency of cryptic variation at the end of phase I (I-4).  
'+' and '-' indicate an incidence or not incidence of a corresponding mutation.   
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Table S7  
Incidence of mutations during each generation of evolution 
Mutation Incidence (%) a 
L43M 0.003 
F47L 1.12 
F65L 0.22 
F65S 0.26 
G66S 0.09 
F72C 0.03 
F72I 0.02 
K102R 0.15 
I129T 0.33 
K141R 0.42 
N145S 0.60 
V164A 0.25 
K167E 0.56 
I168V 0.43 
I172V 0.35 
Y204C 0.26 
a We estimated the incidence of each mutation shown here by linear regression using frequency data of each 
mutation from our directed evolution experiments in the absence of selection (see Fig. S4). We considered the slopes 
of the linear regression lines describing the change in mutation frequency as the mutation incidence. A mutation with 
an incidence of one percent means that mutation pressure alone causes the mutation to appear at a frequency of one 
percent in the absence of selection.  
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Table S8  
Primers for the construction of the expression plasmid and for mutagenic PCR 
Primer Sequence 
Fbad CCC aagctt GTTTAAACGGTCTCCAGCTTG 
Rbad CCGctcgagGTATATCTCCTTCTTAAAGTTAAACAAAAT 
F203 CCG ctcgag ATGGTGAGCAAGGGCGAG 
R203 CCCaagcttTCACTTGTACAGCTCGTCCATGC 
MutfpF GAAGGAGATATACctcgag 
MutfpR AGACCGTTTAAACaagctt 
Lower case letters refer to restriction sites. 
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Table S9  
Mutation incidence per nucleotide site and per cycle of mutagenesis a 
  A T C G 
A 9.97-1 9.46-5 1.02-4 2.49-3 
T 7.33-5 9.98-1 1.97-3 9.16-5 
C 4.41-5 7.72-4 9.99-1 3.00-5 
G 7.50-4 2.43-5 1.11-5 9.99-1 
a We calculated these mutation rates from pooled sequences of non-selected control libraries sequenced by SMRT. 
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Table S10  
Primers for engineering YFP mutants 
Positi
on Mutation Forward primer Reverse primer 
2 V2M CTCGAGATGaTGAGCAAGGGCGAGGAG CCCTTGCTCAtCATCTCGAGGTATATCTC 
2 V2A CTCGAGATGGcGAGCAAGGGCGAGGAGCT CCCTTGCTCgCCATCTCGAGGTATATCTC 
43 L43M TACGGCAAGaTGACCCTGAAGTTCATCTGCACCAC TTCAGGGTCAtCTTGCCGTAGGTGGCATCGCC 
47 F47L CCCTGAAGcTCATCTGCACCACCGGCAAG GTGCAGATGAgCTTCAGGGTCAGCTTGC 
65 F65L TCGTGACCACCcTCGGCTACGGCCTGCAATGC GCCGTAGCCGAgGGTGGTCACGAGGGTGGGC 
65 F65S GACCACCTcCGGCTACGGCCTGCAATGC CGTAGCCGgAGGTGGTCACGAGGGTGGG 
66 G66S TGACCACCTTCaGCTACGGCCTGCAATGCTTCG CAGGCCGTAGCtGAAGGTGGTCACGAGGGTGGG 
72 F72C GCAATGCTgCGCCCGCTACCCCGACCAC AGCGGGCGcAGCATTGCAGGCCGTAGCC 
72 F72I CTGCAATGCaTCGCCCGCTACCCCGACC AGCGGGCGAtGCATTGCAGGCCGTAGCCG 
102 K102R ATCTTCTTCAgGGACGACGGCAACTACAAGAC CGTCGTCCcTGAAGAAGATGGTGCGCTCC 
129 I129T GAAGGGCAcCGACTTCAAGGAGGACGGCAAC TTGAAGTCGgTGCCCTTCAGCTCGATGCGGTTC 
141 K141R GGGGCACAgGCTGGAGTACAACTACAACAG ACTCCAGCcTGTGCCCCAGGATGTTGCCG 
145 N145S GGAGTACAgCTACAACAGCCACAACGTC CTGTTGTAGcTGTACTCCAGCTTGTGCCCCAG 
164 V164A GCATCAAGGcGAACTTCAAGATCCGCCAC CTTGAAGTTCgCCTTGATGCCGTTCTTCTG 
167 K167E TGAACTTCgAGATCCGCCACAACATCGAG GCGGATCTcGAAGTTCACCTTGATGCCGTTC 
168 I168V AACTTCAAGgTCCGCCACAACATCGAGGAC GTGGCGGAcCTTGAAGTTCACCTTGATGCC 
172 I172V CGCCACAACgTCGAGGACGGCAGCGTGCAG GTCCTCGAcGTTGTGGCGGATCTTGAAG 
204 Y204C ACTACCTGAGCTgCCAGTCCGCCCTGAGCAAAG GGGCGGACTGGcAGCTCAGGTAGTGGTTGTCGGGC 
65, 66 F65L+G66Sa CCACCcTCaGCTACGGCCTGCAATGCTTC GGCCGTAGCtGAgGGTGGTCACGAGGGTGGG 
65, 66 F65S+G66Sa GACCACCTcCaGCTACGGCCTGCAATGCTTCG GCCGTAGCtGgAGGTGGTCACGAGGGTGGG 
66, 72 G66S+F72Cb GCAATGCTgCGCCCGCTACCCCGACCAC AGCGGGCGgAGCATTGCAGGCCGTAGCtG 
66, 72 G66S+F72Ib CTGCAATGCaTCGCCCGCTACCCCGACC AGCGGGCGAtGCATTGCAGGCCGTAGCtG 
Lower case letters refer to mutations. 
a we performed whole plasmid PCR by using the ancestral YFP as a template. 
b we performed whole plasmid PCR by using the mutant G66S as a template. 
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Table S11  
Primers for barcoding PCR 
Primer Sequence 
BC01 GGTAGGAGCAATGTAAAACGACGGCCAGT 
BC02 GGTAGGCCTGTTGTAAAACGACGGCCAGT 
BC03 GGTAGGGGGTTTGTAAAACGACGGCCAGT 
BC04 GGTAGGGAAGGCGTAAAACGACGGCCAGT 
BC05 GGTAGGATCTCAGTAAAACGACGGCCAGT 
BC06 GGTAGGATGGATGTAAAACGACGGCCAGT 
BC07 GGTAGGATGTCTGTAAAACGACGGCCAGT 
BC08 GGTAGGCGTGACGTAAAACGACGGCCAGT 
BC09 GGTAGGTTAGGTGTAAAACGACGGCCAGT 
BC10 GGTAGGGTGCATGTAAAACGACGGCCAGT 
BC11 GGTAGGAACTTTGTAAAACGACGGCCAGT 
BC12 GGTAGGGGATCGGTAAAACGACGGCCAGT 
BC13 GGTAGGATAAGGGTAAAACGACGGCCAGT 
BC14 GGTAGGATTGGTGTAAAACGACGGCCAGT 
BC15 GGTAGGAGTGAGGTAAAACGACGGCCAGT 
BC16 GGTAGGCCCACCGTAAAACGACGGCCAGT 
BC17 GGTAGGCGATGCGTAAAACGACGGCCAGT 
BC18 GGTAGGGATAGCGTAAAACGACGGCCAGT 
BC19 GGTAGGGTCAGAGTAAAACGACGGCCAGT 
BC20 GGTAGGTTAAGCGTAAAACGACGGCCAGT 
BC21 GGTAGGAACCTGGTAAAACGACGGCCAGT 
BC22 GGTAGGCTTTGCGTAAAACGACGGCCAGT 
BC23 GGTAGGTGGAGAGTAAAACGACGGCCAGT 
BC24 GGTAGGAATTGTGTAAAACGACGGCCAGT 
BC25 GGTAGGTGACGAGTAAAACGACGGCCAGT 
BC26 GGTAGGCAAATAGTAAAACGACGGCCAGT 
BC27 GGTAGGGTTCAGGTAAAACGACGGCCAGT 
BC28 GGTAGGCTTCAAGTAAAACGACGGCCAGT 
FP_smrtF GTAAAACGACGGCCAGTCTTTAAGAAGGAGATATACCTCGAG 
pBAD849r AATCTTCTCTCATCCGCC 
Underlined sequences refer to barcoding regions. 
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Table S12  
Adapter and barcodes used for barcoding samples 
lbc28 ATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGAT GAGACTCTGTGCGCGT 
lbc36 ATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGAT GCGTATATCTCATGCG 
lbc44 ATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGAT TGTCACTCATCTGAGT 
lbc52 ATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGAT GCAGACTCTCACACGC 
lbc66 ATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGAT CGACTACGTACAGTAG 
lbc68 ATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGAT ACAGTATGATGTACTC 
lbc76 ATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGAT ACGTGAGCTCACTCGC 
lbc84 ATCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGAT GACTGCACATGCACGA 
Underlined sequences refer to barcoding regions.  
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Table S13  
Frequency of genotypes leading to T1 in 01V during evolution 
Mutation Generation 
G66S Y204C F65L II-1 II-2 II-3 II-4 
- - - 81.43 23.26 9.73 5.39 
- - + 0.56 0.16 0.17 0.00 
- + - 5.59 2.17 3.07 3.17 
+ - - 11.86 62.95 25.94 16.64 
- + + 0.11 0.00 0.34 0.16 
+ - + 0.00 0.16 1.19 1.11 
+ + - 0.45 11.32 49.49 60.54 
+ + + 0.00 0.00 10.07 13.00 
Note that the data in green indicate the inferred trajectories with highest probability (see Supplementary Text S3).  
'+' and '-' indicate an incidence or not incidence of a corresponding mutation.  
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Table S14  
Frequency of genotypes leading to T3 in 01V evolution 
Mutation Generation 
G66S Y204C L43M II-1 II-2 II-3 II-4 
- - - 81.88 23.26 9.73 5.39 
- - + 0.11 0.16 0.17 0.00 
- + - 5.37 2.02 2.73 2.85 
+ - - 11.86 62.79 25.94 13.31 
- + + 0.34 0.16 0.68 0.48 
+ - + 0.00 0.31 1.19 4.44 
+ + - 0.45 10.85 50.00 41.52 
+ + + 0.00 0.47 9.56 32.01 
Note that the data in green indicate the inferred trajectories with highest probability (see Supplementary Text S3).  
'+' and '-' indicate an incidence or not incidence of a corresponding mutation.  
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Table S15  
Frequency of genotypes leading to T1 in 02V during evolution 
Mutation Generation 
G66S Y204C F65L II-1 II-2 II-3 II-4 
- - - 70.50 18.19 11.32 5.39 
- - + 0.65 0.28 0.00 0.13 
- + - 6.83 2.68 2.36 2.88 
+ - - 21.04 67.98 24.83 13.16 
- + + 0.11 0.00 0.17 0.25 
+ - + 0.00 0.28 1.69 2.88 
+ + - 0.87 10.30 47.80 53.13 
+ + + 0.00 0.28 11.82 22.18 
Note that the data in green indicate the inferred trajectories with highest probability (see Supplementary Text S3).  
'+' and '-' indicate an incidence or not incidence of a corresponding mutation.  
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Table S16  
Frequency of genotypes leading to T2 in 02V during evolution 
Mutation Generation 
G66S Y204C F47L II-1 II-2 II-3 II-4 
- - - 69.41 18.19 10.30 4.89 
- - + 1.74 0.28 1.01 0.63 
- + - 6.72 2.68 2.53 2.76 
+ - - 20.72 67.84 24.32 14.16 
- + + 0.22 0.00 0.00 0.38 
+ - + 0.33 0.42 2.20 1.88 
+ + - 0.87 9.59 46.62 57.02 
+ + + 0.00 0.99 13.01 18.30 
Note that the data in green indicate the inferred trajectories with highest probability (see Supplementary Text S3).  
'+' and '-' indicate an incidence or not incidence of a corresponding mutation.  
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Table S17  
Frequency of genotypes leading to T1 in 03V during evolution 
Mutation Generation 
G66S Y204C F65L II-1 II-2 II-3 II-4 
- - - 80.44 27.82 9.39 6.30 
- - + 0.70 1.52 0.33 0.22 
- + - 3.59 2.19 3.62 1.96 
+ - - 14.27 54.30 21.75 8.26 
- + + 0.00 0.00 0.49 0.00 
+ - + 0.40 3.71 2.47 3.04 
+ + - 0.60 9.95 42.67 44.78 
+ + + 0.00 0.51 19.28 35.43 
Note that the data in green indicate the inferred trajectories with highest probability (see Supplementary Text S3).  
'+' and '-' indicate an incidence or not incidence of a corresponding mutation.  
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Table S18  
Frequency of genotypes leading to T1 in 04V during evolution 
Mutation Generation 
G66S Y204C F65L II-1 II-2 II-3 II-4 
- - - 81.20 26.31 8.79 6.36 
- - + 0.36 0.13 0.35 0.91 
- + - 3.95 1.74 3.51 5.91 
+ - - 14.25 62.42 25.31 15.45 
- + + 0.00 0.00 0.18 0.00 
+ - + 0.24 0.40 0.70 0.91 
+ + - 0.00 8.86 57.82 53.64 
+ + + 0.00 0.13 3.34 16.82 
Note that the data in green indicate the inferred trajectories with highest probability (see Supplementary Text S3).  
'+' and '-' indicate an incidence or not incidence of a corresponding mutation.  
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Table S19  
Frequency of genotypes leading to T2 in 04V during evolution 
Mutation Generation 
G66S Y204C F47L II-1 II-2 II-3 II-4 
- - - 79.88 26.17 8.79 6.82 
- - + 1.68 0.27 0.35 0.45 
- + - 3.95 1.74 3.51 5.45 
+ - - 14.49 62.28 24.43 15.45 
- + + 0.00 0.00 0.18 0.45 
+ - + 0.00 0.54 1.58 0.91 
+ + - 0.00 8.46 53.43 52.27 
+ + + 0.00 0.54 7.73 18.18 
Note that the data in green indicate the inferred trajectories with highest probability (see Supplementary Text S3).  
'+' and '-' indicate an incidence or not incidence of a corresponding mutation.  
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Table S20  
Frequency of genotypes leading to T2 in 1
CV during evolution 
Mutation   Generation 
G66S Y204C F47L I-4 II-1 II-2 II-3 II-4 
- - - 90.64 47.33 18.28 9.83 5.71 
- - + 8.35 7.57 4.48 2.00 0.66 
- + - 0.65 7.24 5.81 4.45 5.71 
+ - - 0.36 33.07 29.42 14.29 10.49 
- + + 0.00 0.22 1.45 1.08 1.20 
+ - + 0.00 1.45 4.72 2.61 1.86 
+ + - 0.00 2.90 23.73 45.01 65.34 
+ + + 0.00 0.22 12.11 20.74 9.03 
Note that the data in green indicate the inferred trajectories with highest probability (see Supplementary Text S3), 
and the data in yellow indicate the frequency of cryptic variation at the end of phase I (I-4).  
'+' and '-' indicate an incidence or not incidence of a corresponding mutation.  
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Table S21  
Frequency of genotypes leading to A1 in 1
CV during evolution 
Mutation   Generation 
G66S Y204C F65S K102R N145S V164A I-4 II-1 II-2 II-3 II-4 
- - - - - - 94.17 50.56 20.10 9.52 4.38 
- - - - - + 1.51 2.23 0.48 0.46 0.80 
- - - - + - 2.16 1.67 0.97 0.77 0.13 
- - - - + + 0.00 0.00 0.12 0.31 0.40 
- - - + - - 1.01 0.22 0.73 0.46 0.40 
- - - + - + 0.00 0.00 0.00 0.00 0.00 
- - - + + - 0.00 0.00 0.00 0.00 0.13 
- - - + + + 0.00 0.00 0.00 0.00 0.00 
- - + - - - 0.14 0.22 0.24 0.31 0.00 
- - + - - + 0.00 0.00 0.00 0.00 0.13 
- - + - + - 0.00 0.00 0.00 0.00 0.00 
- - + - + + 0.00 0.00 0.00 0.00 0.00 
- - + + - - 0.00 0.00 0.00 0.00 0.00 
- - + + - + 0.00 0.00 0.12 0.00 0.00 
- - + + + - 0.00 0.00 0.00 0.00 0.00 
- - + + + + 0.00 0.00 0.00 0.00 0.00 
- + - - - - 0.65 6.57 5.69 4.15 3.85 
- + - - - + 0.00 0.45 0.24 0.46 0.66 
- + - - + - 0.00 0.33 0.48 0.00 0.53 
- + - - + + 0.00 0.00 0.36 0.77 0.80 
- + - + - - 0.00 0.11 0.12 0.00 0.13 
- + - + - + 0.00 0.00 0.00 0.00 0.00 
- + - + + - 0.00 0.00 0.00 0.00 0.00 
- + - + + + 0.00 0.00 0.36 0.15 0.80 
- + + - - - 0.00 0.00 0.00 0.00 0.00 
- + + - - + 0.00 0.00 0.00 0.00 0.00 
- + + - + - 0.00 0.00 0.00 0.00 0.00 
- + + - + + 0.00 0.00 0.00 0.00 0.13 
- + + + - - 0.00 0.00 0.00 0.00 0.00 
- + + + - + 0.00 0.00 0.00 0.00 0.00 
- + + + + - 0.00 0.00 0.00 0.00 0.00 
- + + + + + 0.00 0.00 0.00 0.00 0.00 
+ - - - - - 0.36 27.62 26.88 9.83 6.91 
+ - - - - + 0.00 4.90 3.27 1.69 1.33 
+ - - - + - 0.00 0.67 0.48 0.92 0.66 
+ - - - + + 0.00 0.00 0.85 0.31 0.66 
+ - - + - - 0.00 0.45 0.00 0.46 0.13 
+ - - + - + 0.00 0.89 1.09 1.08 0.80 
+ - - + + - 0.00 0.00 0.00 0.00 0.00 
+ - - + + + 0.00 0.00 0.24 0.00 0.27 
+ - + - - - 0.00 0.00 0.36 0.46 0.40 
+ - + - - + 0.00 0.00 0.24 0.31 0.13 
+ - + - + - 0.00 0.00 0.12 0.15 0.13 
+ - + - + + 0.00 0.00 0.24 0.77 0.66 
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+ - + + - - 0.00 0.00 0.24 0.00 0.13 
+ - + + - + 0.00 0.00 0.12 0.00 0.00 
+ - + + + - 0.00 0.00 0.00 0.00 0.00 
+ - + + + + 0.00 0.00 0.00 0.92 0.13 
+ + - - - - 0.00 2.23 22.88 34.25 35.99 
+ + - - - + 0.00 0.00 0.85 3.69 4.65 
+ + - - + - 0.00 0.11 1.45 3.07 3.32 
+ + - - + + 0.00 0.00 2.18 3.07 5.44 
+ + - + - - 0.00 0.00 0.12 0.00 0.40 
+ + - + - + 0.00 0.00 0.12 0.15 0.40 
+ + - + + - 0.00 0.00 0.12 0.15 0.27 
+ + - + + + 0.00 0.11 0.24 1.54 1.73 
+ + + - - - 0.00 0.00 0.48 1.54 1.73 
+ + + - - + 0.00 0.00 0.48 0.77 1.20 
+ + + - + - 0.00 0.00 0.73 0.46 1.06 
+ + + - + + 0.00 0.11 1.82 3.53 4.91 
+ + + + - - 0.00 0.00 0.00 0.00 0.00 
+ + + + - + 0.00 0.00 0.12 0.15 0.13 
+ + + + + - 0.00 0.00 0.00 0.31 0.27 
+ + + + + + 0.00 0.56 4.24 13.06 12.88 
Note that the data in green indicate the inferred trajectories with highest probability (see Supplementary Text S3), 
and the data in yellow indicate the frequency of cryptic variation at the end of phase I (I-4).  
'+' and '-' indicate an incidence or not incidence of a corresponding mutation.  
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Table S22  
Frequency of genotypes leading to A2 in 1
CV during evolution 
Mutation     Generation     
G66S Y204C F72I K167E I172V I-4 II-1 II-2 II-3 II-4 
- - - - - 94.82 51.78 21.31 11.06 5.31 
- - - - + 1.80 2.45 0.61 0.31 0.53 
- - - + - 2.16 0.67 0.85 0.46 0.00 
- - - + + 0.14 0.00 0.00 0.00 0.27 
- - + - - 0.07 0.00 0.00 0.00 0.00 
- - + - + 0.00 0.00 0.00 0.00 0.00 
- - + + - 0.00 0.00 0.00 0.00 0.27 
- - + + + 0.00 0.00 0.00 0.00 0.00 
- + - - - 0.65 5.35 6.42 4.45 5.31 
- + - - + 0.00 1.89 0.61 0.92 0.66 
- + - + - 0.00 0.11 0.12 0.00 0.40 
- + - + + 0.00 0.11 0.12 0.15 0.27 
- + + - - 0.00 0.00 0.00 0.00 0.13 
- + + - + 0.00 0.00 0.00 0.00 0.00 
- + + + - 0.00 0.00 0.00 0.00 0.13 
- + + + + 0.00 0.00 0.00 0.00 0.00 
+ - - - - 0.29 30.51 29.78 14.29 9.43 
+ - - - + 0.07 3.67 3.75 1.38 0.93 
+ - - + - 0.00 0.33 0.48 0.77 0.27 
+ - - + + 0.00 0.00 0.00 0.00 0.00 
+ - + - - 0.00 0.00 0.00 0.31 0.66 
+ - + - + 0.00 0.00 0.12 0.00 0.53 
+ - + + - 0.00 0.00 0.00 0.00 0.40 
+ - + + + 0.00 0.00 0.00 0.15 0.13 
+ + - - - 0.00 2.45 33.41 54.84 38.91 
+ + - - + 0.00 0.56 1.82 4.45 14.87 
+ + - + - 0.00 0.00 0.48 1.08 2.92 
+ + - + + 0.00 0.11 0.00 0.31 5.44 
+ + + - - 0.00 0.00 0.00 0.61 1.99 
+ + + - + 0.00 0.00 0.00 0.46 1.46 
+ + + + - 0.00 0.00 0.00 0.77 1.99 
+ + + + + 0.00 0.00 0.12 3.23 6.77 
Note that the data in green indicate the inferred trajectories with highest probability (see Supplementary Text S3), 
and the data in yellow indicate the frequency of cryptic variation at the end of phase I (I-4).  
'+' and '-' indicate an incidence or not incidence of a corresponding mutation.  
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Table S23  
Frequency of genotypes leading to T1 in 2
CV during evolution 
Mutation Generation 
G66S Y204C F65L I-4 II-1 II-2 II-3 II-4 
- - - 96.86 58.82 26.59 12.92 12.84 
- - + 1.69 3.24 1.56 1.11 0.90 
- + - 0.97 6.84 4.98 6.46 5.42 
+ - - 0.36 27.13 38.26 23.25 16.09 
- + + 0.12 0.96 0.31 1.11 0.36 
+ - + 0.00 1.56 6.69 4.61 3.98 
+ + - 0.00 1.32 15.55 29.52 30.02 
+ + + 0.00 0.12 6.07 21.03 30.38 
Note that the data in green indicate the inferred trajectories with highest probability (see Supplementary Text S3), 
and the data in yellow indicate the frequency of cryptic variation at the end of phase I (I-4).  
'+' and '-' indicate an incidence or not incidence of a corresponding mutation.  
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Table S24  
Frequency of genotypes leading to A3 in 3
CV during evolution 
Mutation     Generation     
G66S Y204C F47L I129T K141R I-4 II-1 II-2 II-3 II-4 
- - - - - 87.92 53.19 19.02 6.02 5.73 
- - - - + 1.23 0.43 1.53 0.26 0.38 
- - - + - 0.80 1.08 0.34 0.65 0.19 
- - - + + 0.00 0.00 0.00 0.00 0.38 
- - + - - 8.18 7.14 3.74 2.23 2.10 
- - + - + 0.22 0.00 0.00 0.26 0.19 
- - + + - 0.07 0.22 0.51 0.13 0.19 
- - + + + 0.00 0.11 0.00 0.13 0.00 
- + - - - 1.09 11.14 3.90 2.62 2.29 
- + - - + 0.00 0.00 0.51 0.65 0.38 
- + - + - 0.00 0.32 0.17 0.26 0.57 
- + - + + 0.00 0.00 0.85 0.00 1.34 
- + + - - 0.14 1.19 1.19 0.79 1.34 
- + + - + 0.00 0.11 0.34 0.39 0.00 
- + + + - 0.00 0.00 0.34 0.26 0.00 
- + + + + 0.00 0.22 0.68 0.39 0.95 
+ - - - - 0.36 16.11 10.19 4.97 2.10 
+ - - - + 0.00 0.43 0.34 0.26 0.00 
+ - - + - 0.00 0.43 0.34 0.39 0.38 
+ - - + + 0.00 0.11 0.00 0.13 0.19 
+ - + - - 0.00 1.73 4.58 2.36 3.63 
+ - + - + 0.00 0.22 0.85 0.52 0.76 
+ - + + - 0.00 0.11 0.51 0.13 0.76 
+ - + + + 0.00 0.11 1.53 0.79 2.10 
+ + - - - 0.00 2.59 6.79 3.53 3.24 
+ + - - + 0.00 0.11 0.85 0.65 1.34 
+ + - + - 0.00 0.32 1.02 0.65 0.19 
+ + - + + 0.00 0.11 1.02 0.52 0.57 
+ + + - - 0.00 1.08 5.43 4.58 3.44 
+ + + - + 0.00 0.11 3.57 3.27 7.25 
+ + + + - 0.00 0.22 0.34 1.83 1.53 
+ + + + + 0.00 1.08 29.54 60.34 56.49 
Note that the data in green indicate the inferred trajectories with highest probability (see Supplementary Text S3), 
and the data in yellow indicate the frequency of cryptic variation at the end of phase I (I-4).  
'+' and '-' indicate an incidence or not incidence of a corresponding mutation.  
 
